Design of a thermal diffusion sensor for noninvasive assessment of skin surface perfusion and endothelial dysfunction by Li, Vivian V. (Vivian Victoria)
Design of a Thermal Diffusion Sensor for Noninvasive Assessment of
Skin Surface Perfusion and Endothelial Dysfunction
by
Vivian V. Li
S.B., Mechanical Engineering
hU_ i.. fC hU l1
MASSACHUS T
OF TEOHNOL
JUN 2 0 2
LIBRARI
1Via•cllUstLL Int111LULe; II 1 •;IIUgIUy•, LVVU
Submitted to the Harvard-MIT Division of Health Sciences and Technology Aii;
in Partial Fulfillment of the Requirements for the Degree of
MASTER OF ENGINEERING IN BIOMEDICAL ENGINEERING
at the
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
OGY
008
ES
June 2008
02008 Massachusetts Institute of Technology
All rights reserved
i
Signature of Author:
Certified by:
INarvard-MIT Dlision of Health Sciences and Technology
May 22, 2008
H. Frederick Bowman, Ph.D.
Senior Academic Administrator
Harvard-MIT Division of Health Sciences and Technology
Thesis Supervisor
Accepted by:
Martha L. Gray, Ph.D.
Edward Hood Taplin Professor ofMedical and Electrical Engineering
Director, Harvard-MIT Division of Health Sciences and Technology
'
J

Design of a Thermal Diffusion Sensor for Noninvasive Assessment of
Skin Surface Perfusion and Endothelial Dysfunction
by
Vivian V. Li
Submitted to the Harvard-MIT Division of Health Sciences and Technology on
May 22, 2008 in Partial Fulfillment of the Requirements for the
Degree of Master of Engineering in Biomedical Engineering
Abstract
The skin microcirculation performs a range of vital functions, such as maintaining nutritional perfusion to
the tissues and overall thermoregulation. Not only does impairment to the skin blood supply lead to tissue
necrosis and other disease complications, increasing evidence shows that dysfunctional vasoreactivity in
the skin microcirculation is associated with multiple disease states, including hypertension, diabetes
mellitus, hypercholesterolemia, peripheral vascular disease, and coronary artery disease, and it is one of
the earliest indicators of systemic endothelial dysfunction, the precursor to atherosclerotic disease.
Endothelial dysfunction is functionally characterized by abnormal vasomotor response to either a
pharmacological or flow-mediated stimulus and can be demonstrated in the skin by measuring reperfusion
following a period of ischemia, a phenomenon known as post-occlusive reactive hyperemia (PORH).
In my research, I have reviewed the literature regarding endothelial dysfunction and its association with a
wide range of cardiovascular risk factors. I have also described the mechanisms thought to link
endothelial function in the central vascular beds (i.e. coronary) to that of peripheral conduit vessels and
the microcirculation. The knowledge thus gathered confirmed that the microcirculation of the skin is an
appropriate site for endothelial function assessment. The ultimate goal of my thesis is to design a
noninvasive sensor that is capable of obtaining a quantitative measure of skin perfusion, continuously and
in real-time, using the principle of thermal diffusion in perfused tissue.
I performed preliminary noninvasive endothelial function testing with a modified Thermal Diffusion
Probe (TDP), which has been previously validated for absolute perfusion measurement in an invasive
setting. Based on an initial analysis, I have shown that thermal surface perfusion measurements are
feasible and reflect the natural perfusion and temperature fluctuations intrinsic to skin tissue. I also
established guidelines for determining quantitative parameters of reactivity from tests of PORH as well as
temporal parameters of perfusion variations over time through a spectral analysis of resting blood flow.
After establishing the necessary thermal boundary conditions for obtaining surface perfusion
measurements, I embarked on a process of computer-assisted modeling and rapid prototyping of various
design iterations on an insulated sensor housing, with subsequent fabrication of first generation
noninvasive sensors. As a result of these initial sensor designs, specifications for the sensor housing were
created to ensure that the appropriate thermal field would be established at the skin measurement site - an
important step as it permits the most accurate determination of tissue thermal properties. Finally, I
propose a candidate design for an ideal sensor capable of improving the reproducibility of noninvasive
perfusion measurements on skin.
The development of a noninvasive measure of endothelial dysfunction in the skin is of great value in the
early identification of individuals at risk for atherosclerotic complications. Furthermore, the nature of
such a technique would provide quantitative information on the presence of a disorder, the extent of
dysfunction, and the effectiveness of treatment interventions.
Thesis Supervisor: H. Frederick Bowman, Ph.D.
Title: Senior Academic Administrator, Harvard-MIT Division of Health Sciences and Technology

Acknowledgements
The research I have completed and the knowledge I have gained would not have been possible
without the support and guidance of my advisor, Fred Bowman. He has been a true advocate for
my education and future aspirations, always inspiring me to overcome any frustrations or
obstacles encountered along the way.
I am also grateful to Dr. Robert Lees, who provided me with the clinical perspective I needed to
understand the implications of my research. His patient-centered outlook has guided my own
path between the fields of engineering and medicine.
I wish to thank the entire engineering team at Thermal Technologies and Hemedex. Their
endless patience as well as their willingness to share their time and resources has contributed a
great deal to my understanding of the thermal diffusion probe and to the preparation of my
thesis.
A special thanks goes to my parents, Jan and Tien-Sheng Li, who have supported my personal
and educational ambitions all along the way. I am also fortunate to have my wonderful sisters,
Jing and Melissa, who have always been there to make me laugh and enjoy life outside of MIT.
I would also like to thank my friends, who inspire me with their enthusiasm and passion every
day. In particular, I would like to thank Chewie, whose delight in "making small things look big"
aided in the high-magnification photos of certain sensor components; Francisco, for his immense
MATLAB expertise; and Charles, whose continual encouragement and editing suggestions have
helped me prepare the thesis presented herein.
The funding that made this work possible was provided in part by the Boston Heart Foundation,
the Harvard-MIT Division of Health Sciences and Technology, the National Institutes of Health
(Grant 5R43DK070408), and Thermal Technologies of Cambridge, MA.

Table of Contents
Abstract ........................................................................................................................................................ 3
Acknowledgem ents ................................................................................................................ 5
Table of Contents ................................................................................................................... 7
List of Figures .............................................................................................................................. 11
List of Tables ................................................ 13
List of Sym bols ............................................................................................................................ 14
List of Term s and Abbreviations ............................................................................................... 15
Chapter 1. Introduction ........................................................................................................... 16
1.1 M otivation ..................................................................................................................................... 16
1.2 Objectives of Research ................................................................................................................. 17
Chapter 2. Skin Microvascular Physiology .......................................... ............... 20
2.1 Organization of the M icrocirculation ................................................................ ......................... 20
2.1.1 Arteries & Arterioles ..................................................................................................................... 21
2.1.2 Capillaries........................................ 22
2.1.3 Venules & Veins ................................................ 23
2.2 Levels of Blood Flow Regulation....................................................................................................... 23
2.3 Skin Blood Flow: Roles in Tissue Nutrition and Thermoregulation ..................................... . 25
2.4 Reactive Hyperem ia .................................................... 26
2.5 Skin M icrocirculation in Health and Disease................................................ 27
Chapter 3. Endothelial Dysfunction & Methods of Assessment............................... 28
3.1 Pathophysiology of Endothelial Dysfunction ........................................................................ 28
3.2 Systemic Impact of Endothelial Dysfunction and Atherosclerosis......................... ........ 31
3.3 Techniques for the Assessm ent of Endothelial Dysfunction ....................................... .... .. 34
3.3.1 Intracoronary Studies..................................................................................................................... 34
7
3.3.2 Strain-Gauge Venous Occlusion Plethysmography (VOP) ...................................... ....... 35
3.3.3 Brachial Artery Ultrasound Measurement of Endothelium-Dependent Flow-Mediated Dilatation
(F M D )..................................................................... .......................................... .. ....................... 3 7
3.4 Current Methods for Noninvasive Evaluation of the Microcirculation ..................................... 39
3.4.1 Laser D oppler Flow m etry.............................. ......... ...... ............................ ....................... 39
3.4.2 Orthogonal Polarization Spectral (OPS) Imaging .................... .................. 42
3.4.3 Peripheral Arterial Tonometry (PAT) ....................................... ...................... 43
3.5 Current Methods of Noninvasive Assessment: Thermal Methods.......................... ...... 45
3.5.1 Skin Surface Temperature Gradients.............................. ......................... 45
3.5.2 Thermal Clearance ...............................  ....................... 46
3.5.3 Convective Perfusion Bioprobe...................................................... ........... ................... 48
3.5.4 Digital Thermal M onitoring (DTM )............................... ........ ........... ..................... 49
3.6 Clinical Implications of Noninvasive Endothelial Function Assessment.................. 52
3.6.1 Epidemiology .............. .. ..... .................................... 52
3.6.2 R isk A ssessm ent ........................... ... ... ....... ... ... . ... ... .... ............................ 53
3.6.2 Prim ary Prevention .............................. ................................. 53
Chapter 4. Heat Transfer Mechanisms and Tissue Perfusion ..................................... . 55
4.1 H eat Transfer Principles ................................... . ........................ 55
4.2 Thermal M odel of Bio-Heat Transfer .......................... .. .. .... .. ..... ....................... 56
4.3 History of Thermal Tissue Perfusion Measurements................................ 58
Chapter 5. Noninvasive Application of the TDP Probe...................... ......... 60
5.1 The Invasive Perfusion Probe: Design and Operation.................................................... 60
5.1.1 D esign................................... .................... 60
5.1.2 Calibration .................. .................... ... .......... . ......... ...................... 63
5.2 Adapting Invasive Probe for Noninvasive Measurement .......................... ........ ..... 64
5.2.1 Sensor Placem ent ............................. .  ... ............................ 64
5.2.2 Sensor-Tissue Surface Geom etry ............................................................. ....................... 65
5.2.3 Contact Pressure ............................ ........... ........................................... 66
5.2.4 Exposed Thermistor Beads ............................................................. ....... ............... 67
5.3 Measurement Protocol: Post-Ischemic Reactive Hyperemia (PORH) ..................................... 68
5.3.1 Experimental Considerations ....................................... 68
5.3.2 Protocol ........................................ ......... ......... ......... ...... .................. 68
5.4 M easurem ent Issues ............................... ..... ......................... ............ 71
5.4.1 M otion Artifacts ........................................ .. ... .................. ...... ................. 71
5.4.2 Sensor-Surface Tissue Contact .......................... .... ...... ................................... 72
5.4.3 Undetectable Baseline Perfusion.............................................................................................. 72
5.4.4 Non-zero Perfusion During Occlusion ............................................................. ....................... 73
5.5 Physiological Issues ............................................................................................................................ 75
5.5.1 Baseline Temperature Fluctuations ................................................................ ......................... 75
5.5.2 Variability of km ......................................................................... 76
5.5.3 M ulti-Phasic Perfusion Hyperem ia ................................................................ ......................... 78
5.6 M ethods of Data Analysis .................................................................................................................. 80
5.6.1 Filtering ......................................................................................................................................... 80
5.6.2 Perfusion Analysis............................................ 80
5.6.3 Temperature Analysis.................................................................................................................... 82
5.6.4 Frequency Analysis .................................................. 84
5.7 Exam ples of Subject Data .................................................................................................................. 85
5.7.1 24 year old M ale, Healthy .................................................................... ............................ 86
5.7.2 30 year old M ale, Cigarette Sm oker....................................................................................... 87
Chapter 6. Design of the Noninvasive Sensor ................................................................ 88
6.1 Design Issues to Address .................................................................................................................... 88
6.2 G eom etry ............................................................................................................................................. 89
6.2.1 Disk ............................................................................................................................................... 89
6.2.2 Hem isphere......................................... 89
6.3 Tissue-Sensor Interface ................................................... 90
6.4 Sensor Fixation and Placem ent ...................................................................... ............................. 90
6.5 Initial Designs and Rapid Prototyping .............................................................. ......................... 91
6.5.1 M olded Design ................................................. 91
6.5.2 Extruded Design ................................................. 93
6.6 Proposed Sensor Design ..................................................................................................................... 97
6.6.1 Design and Manufacture of Sensor Housing............................................... 98
6.7 Calibration ................................................... 99
6.8 Sensor Assem bly ............................................................................................................................... 100
Chapter 7. Conclusion and Recommendations ..................................... 103
Chapter 8. Bibliography ........................................ 105

List of Figures
Figure 2.1 Layers of skin with microvascular ultrastructure ........................................ ..... 21
Figure 2.2 Vessels of the circulatory system ..................................................................... 24
Figure 3.1 Regulatory functions of the endothelium ........................................ ...... 28
Figure 3.2 Endothelial dysfunction as an index of overall cardiovascular risk ......................... 31
Figure 3.3 Venous Occlusion Plethysmography (VOP) measures the changes in blood volume
within a limb during short periods of venous occlusion ...................................... 36
Figure 3.4 Brachial artery ultrasonography and endothelial function testing........................... 37
Figure 3.5 Basic operating principles of laser Doppler flowmetry (LDF) ............................... 40
Figure 3.6 Representative LDF measurement during test of Post-Occlusive Reactive Hyperemia
(P O R H ) ............................................................................................................................. 4 1
Figure 3.7 RH-PAT finger plethysmographic device developed by Itamar Medical ................... 43
Figure 3.8 Representative RH-PAT signal recorded in subjects with normal and abnormal
reactive hyperem ic responses ........................................................... .......................... 44
Figure 3.9 Parameters of Digital Thermal Monitoring (DTM) test of endothelial dysfunction... 50
Figure 3.10 VENDYS ®  technology ............................................................... ......................... 51
Figure 5.1 The minimally invasive thermal diffusion probe (TDP) produced by Hemedex, Inc.60
Figure 5.2 Temperature profile of the thermistor probe and tissue before and after heating ....... 61
Figure 5.3 Noninvasive sensor measurement locations on palmar face of hand ....................... 65
Figure 5.4 Schematic cross-section of exposed thermistors in TDP resting on surface of tissue. 66
Figure 5.5 Bowman Perfusion Monitor and modified thermal diffusion probe (TDP) for
noninvasive application ................................................................. ............................. 67
Figure 5.6 Outline of PORH test procedure..................................................................... 70
Figure 5.7 Perfusion and temperature are measured during an occlusive challenge to the arm.. 70
Figure 5.8 Motion artifact during perfusion measurement ................................................ 71
Figure 5.9 Baseline measurement is undetectable ................................................... ........... 72
Figure 5.10 Perfusion during occlusion does not reflect absolute zero flow (no flow) ............. 74
Figure 5.11 Temperature fluctuations in resting skin perfusion and temperature ..................... 76
Figure 5.12 Measured intrinsic thermal conductivity of skin (km) before and after occlusion in
test of PO R H ..................................................................................................................... 78
Figure 5.13 Biphasic reactive hyperemia following occlusion............................. ....... 79
Figure 5.14 Representative PORH perfusion measurement with suggested parameters of
reactivity ........................................................................................................................... 82
Figure 5.15 Representative PORH temperature measurement with suggested parameters of
reactiv ity ........................................................................................................................... 83
Figure 5.16 Spectral analysis of perfusion signal measured by thermal sensor ........................ 85
Figure 5.17 Perfusion and Temperature during test of PORH in 24 year old, healthy male........ 86
Figure 5.18 Perfusion and Temperature during test of PORH in 30 year old, male, smoker....... 87
Figure 6.1 Two-dimensional noninvasive designs with corresponding one-dimensional models
considered by Charles, 2004 .................................................................................... ...... 90
Figure 6.2 Solid model of proposed thermistor bead holder, designed by Savage, 2007........ 92
Figure 6.3 Three-dimensional printed acrylic prototype thermistor bead holder .............. 92
Figure 6.4 Plastic extruder cut away to reveal operating components .................................... 94
Figure 6.5 Extruded tubing with channels designed for thermistor beads fixed at specified depths
relative to the skin surface ............................................................... ........................... 95
Figure 6.6 Multiple perspectives of solid model and prototype of alternative extruded housing
d esig n ................................................................................................................................ 9 6
Figure 6.7 Dimensioned cross-section of sensor housing for extrusion die manufacture ........ 99
Figure 6.8 Three-dimensional model of a small length of sensor housing extrusion ............... 99
Figure 6.9 Cross-section of thermistor beads placed in sensor housing .................................. 100
Figure 6.10 Complete assembly of proposed noninvasive surface perfusion sensor .............. 101
Figure 6.11 Schematic cross-section of assembled noninvasive sensor resting on surface of tissue
........... .. . .......................... 102
List of Tables
Table 3.1 Factors associated with endothelial dysfunction in the literature and investigated
therapies that improve endothelial dysfunction ....................................... ........ 30
Table 3.2 Endothelial function assessment in standard clinical practice............................ . 54
List of Symbols
Heat Transfer Symbols
a Thermistor probe radius calibration constant (cm)
C1  Zeroth order Steinhart-Hart calibration constant
C2  First order Steinhart-Hart calibration constant
C3  Third order Steinhart-Hart calibration constant
Cbl Specific heat of blood (W- s/g- C)
k Thermal conductivity (mW/cm. C)
kb Sensor thermal conductivity
km Tissue intrinsic thermal conductivity
P Power (mW)
q Heat flux vector (W/m2)
hbl Volumetric heat exchange between blood and tissue (W/mL)
49 Metabolic volumetric heat exchange (W/ml)
t Time (s)
AT Volume average sensor temperature rise above baseline (oC)
Ti Initial baseline tissue temperature (oC)
V Sensor Volume
rmM Tissue intrinsic thermal diffusivity (cm 2/s)
Pbl Density of blood (g/mL)
W Perfusion (ml/min- 100g)
Perfusion and Temperature Response Parameters
(Opeak Amplitude of post-occlusion peak perfusion
Maximum increase of perfusion during reactive hyperemia compared to baseline
m(Opeak - mean baseline perfusion)
O% Percent hyperemic response = (xeak-Mean Baseline Perusion X 100
Mean Baseline Perfusion
C0AUC Area under the perfusion curve following release
TTP(o Time-to-peak perfusion
Vmean Mean velocity of the post-occlusion hyperemia increase = WpeakTTPCo
TNp Nadir-to-peak temperature change (Tpeak - Tnadir)
TR Temperature recovery, defined as Tpeak - Tinitial (initial pre-occlusion temperature)
T% Percent temperature rebound = TR X 100Tinitial 
-Tnadir
TAUC Area under the temperature curve
TTPT Time-to-peak temperature
List of Terms and Abbreviations
ACE Angiotensin Converting Enzyme
Ach Acetylcholine
AVA Arteriovenous Anastomoses
CAD or CHD Coronary Artery Disease or Coronary Heart Disease
CVD Cardiovascular Disease
DTM Digital Thermal Monitoring (Endothelix, Inc.)
EDHF Endothelium-Derived Hyperpolarizing Factor
EDRF Endothelium-Derived Relaxing Factor (later known as Nitric Oxide, NO)
FBF Forearm Blood Flow
FCD Functional Capillary Density
FMD Flow-Mediated Dilatation
HDL High-Density Lipoprotein
HF Heart Failure
LDF Laser Doppler Flowmetry
LDI Laser Doppler Imaging
LDL Low-Density Lipoprotein
MRI Magnetic Resonance Imaging
NO Nitric Oxide
NTC Negative Temperature Coefficient
OPS Orthogonal Polarization Spectral Imaging
PAD Peripheral Artery Disease
PAT Peripheral Arterial Tonometry
PET Positron Emission Tomography
PORH Post-Occlusive Reactive Hyperemia
PWA Pulse Wave Amplitude
RBC Red Blood Cell
RH Reactive Hyperemia
RH-PAT Reactive Hyperemia Peripheral Arterial Tonometry (Itamar Medical)
RTD Resistance Temperature Detector
SMC Smooth Muscle Cell
TDP Thermal Diffusion Probe (Hemedex, Inc.)
VOP Venous Occlusion Plethysmography
Introduction
1.1 Motivation
The microcirculation of tissues and organs is a vital component of the body's cardiovascular
network. Blood flow at this level is generally known as perfusion and is comprised of the
smallest blood vessels in the body. In addition to regulating the blood flow to individual organs,
perfusion is responsible for a number of critical functions including oxygen delivery, carbon
dioxide and waste product removal, targeted transport of substances (e.g. blood cells, platelets,
hormones), thermoregulation, and blood volume distribution. The efficiency of the circulatory
system is demonstrated by the careful balance of blood flow between vital organs (e.g. heart,
brain) and peripheral tissues (e.g. skin). This balance is maintained by local as well as global
mechanisms which ensure that perfusion matches tissue metabolic and functional needs.
An important local regulator of tissue blood flow is the vascular endothelium, which lines the
interior walls of blood vessels. Although the endothelium has many functional roles, the term
"endothelial function" generally refers to the ability of the endothelium to release compounds
that induce relaxation of the smooth muscle cells within the vascular wall. Endothelial
dysfunction is thus defined as an impairment of endothelium-dependent vasodilatation due to an
imbalance in the bioavailability of endothelium-derived vasodilators or vasoconstrictors.
Additional elaborations on current scientific understanding of endothelial dysfunction have
characterized this state as being prone to atherogenesis through a combination of
proinflammatory, proliferative, and procoagulatory states [1]. Current evidence shows that
endothelial dysfunction is an early marker of atherosclerosis and is implicated in an entire
spectrum of cardiovascular diseases.
While most studies have focused on studying endothelial dysfunction in either the coronary or
brachial arteries, the microcirculation has also been shown to display functional abnormalities.
These abnormalities have typically been regarded as a secondary phenomenon in pathological
disease states. However, the development of methods to evaluate the microcirculation have
challenged this assumption with evidence that microvascular dysfunction plays a key role in the
pathogenesis and pathophysiology of a large range of diseases. A significant association has been
shown to exist between microvascular dysfunction and diseases such as hypertension, diabetes
mellitus, coronary artery disease (CAD), atherosclerosis, and peripheral arterial disease (PAD).
Just as endothelial dysfunction in coronary arteries has been shown to precede the physical
presence of atherosclerosis [2], impaired microvascular reactivity may actually precede disorders
of the systemic circulation.
Interest in this area has established a vast field of research and development aimed at evaluating
microvascular perfusion in vivo. Often, the most reliable, quantitative methods are invasive,
involve complicated procedures, do not permit continuous data collection, and are relatively
expensive. As a result, there is a strong demand for a routine, noninvasive method for assessing
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absolute perfusion in appropriate and accessible tissues, particularly in the skin. Not only would
such a method hold great potential clinical value in the early identification of patients at risk for
cardiovascular complications, but it would also permit noninvasive assessment of wound healing
ability, diabetic skin complications, tissue graft perfusion following reconstructive surgery,
extent of ischemia and multiple other disorders of the skin perfusion. Other applications include
shock monitoring in critical care settings and the development of a microcirculatory index to
assess the impact of drugs, diet, or lifestyle changes. Perfusion in the skin is thus positioned to
play a pivotal role in clinical diagnosis, prognosis, and treatment of major systemic disorders as
well as in research of the microcirculation.
1.2 Objectives of Research
Early identification of the preclinical signs of atherosclerosis is a necessary target for technical
innovation in noninvasive diagnostics as well as patient risk management. The development of a
sensitive screening tool to detect endothelial dysfunction early in a person's life has the potential
to identify pre-symptomatic individuals at a high risk of atherosclerotic complications.
Considering the substantial medical resources dedicated to cardiovascular complications (heart
disease, diabetes, stroke, etc.), early diagnosis shifts the burden of acute care towards the vital
implementation of primary preventive strategies. Ideally, a test of endothelial function should be
inexpensive, noninvasive, safe, repeatable, reproducible, and clearly standardized between
different laboratories [3]. Although several methods for evaluating endothelial function exist, no
technique meets all the above criteria.
Endothelial dysfunction has been established as a systemic disorder that manifests in the
coronary arteries, peripheral conduit arteries, and the peripheral microvasculature. Due to its
superficial location and extensive vascularity, the skin microcirculation is an appropriate
vascular bed for assessing relevant defects in vascular reactivity, functional capillary density, and
tissue blood perfusion. Skin perfusion measurement, in particular, is a field of research with a
wide range of clinically important applications. A diverse body of literature addresses the
methods of measuring the individual aspects of skin blood flow (capillary morphology, red blood
cell velocity, 02 concentration, etc.). However, nearly all have fallen short of developing a
noninvasive technique that delivers an absolute measure of the blood flow in the skin. The ideal
device for measuring superficial tissue perfusion has been previously defined for reconstructive
surgery applications [4, 5]. Generally, such a technique would be able to provide reliable,
sensitive, and continuous data in real-time so that rapid changes in blood flow could be detected.
It would be able to track blood flow in a variety of tissues and the monitoring system would be
simple to use, safe, inexpensive and portable. The blood flow sensor itself would be noninvasive,
not only for patient comfort and safety in routine clinical use, but also to eliminate the effects of
tissue trauma on perfusion.
A clinical method of monitoring perfusion has been developed for invasive applications which
enables determination of absolute blood flow values based on the physiological heat transfer
properties of perfused tissue [6]. This technique has demonstrated significant potential for
obtaining precise, continuous, and real-time assessments of absolute tissue blood flow
invasively, as it must be inserted into (and completely surrounded by) soft tissue. The Thermal
Diffusion Probe (TDP) developed by Bowman, et al. has been validated and successfully used
for monitoring perfusion following human liver transplantation [7] as well as for monitoring
cerebral blood flow in patients with traumatic brain injury [8]. It has also been used to determine
the viability of prefabricated skin flaps used for reconstructive surgery [5]. While this device
possesses the desired characteristics of continuous measurement of absolute perfusion, the
invasive nature of its design limits its applicability in many desired areas. However, the thermal
model of the TDP could theoretically be adapted to the geometry of surface perfusion
measurements.
The concepts behind the TDP operation are based on thermal models of the interaction between
tissue and blood flow. These two components account for the dominant modes of heat transfer in
living tissue such that a tissue's thermal conductivity and thermal diffusivity govern how heat is
distributed over time. A mathematical model can simplify the complex thermal interactions
between conduction, perfusion, and metabolism in vascularized tissue, despite considerable
anisotropy and non-homogeneity. The advantage of such a model lies in the ability to calculate a
value for blood flow based on empirically determined thermal properties. This thesis addresses
the design of a thermal sensor that can monitor perfusion in skin using heat as an inert diffusible
tracer. The noninvasive sensor is based on the invasive TDP, which has proven to be sensitive to
skin blood flow when applied to the tissue surface with an appropriate contact geometry and
pressure. Because of its low cost and non-invasiveness, thermal diffusion may be an ideal
method for assessing endothelial function by measuring reactive hyperemia responsiveness.
Further improvements on such a design would be a significant realization of the need for a safe
and widely applicable method of measuring tissue blood flow.
To begin, I will address the multiple, interconnected elements that must be considered for the
development of a truly noninvasive skin surface perfusion sensor, with particular focus on the
assessment of endothelial dysfunction. Such an understanding requires a reverence for the
physiological structure and regulation of skin blood flow that has made previous attempts in this
field so difficult to interpret.
I will devote a great deal of attention to the systemic mechanisms of endothelial dysfunction as it
relates to the inherent physiological relationship between various vascular beds in the body.
Descriptions of the alternative techniques for assessing endothelial dysfunction are provided to
establish a foundation for the methodology as well as a discussion of the challenges that confront
peripheral vascular measurements. From the accumulated knowledge of vasoreactivity testing, I
hope one can appreciate the breadth of previously documented findings for studies within the
peripheral circulation. Additionally, appropriate design parameters which relate to device
operation, cost, complexity, clinical applicability, and functional constraints of user and patient
interaction can also be gauged from the alternative technologies available.
I will also discuss the methods that have been developed within the field of noninvasive tissue
perfusion measurement, with a focus on thermal modalities. Particular attention is given to
thermal diffusion methods and the heat transfer modeling that enables quantification of absolute
blood flow values as these form the foundation for my noninvasive thermal sensor design.
I will present the preliminary observations from a noninvasive application of the Thermal
Diffusion Probe for functional reactive hyperemia measurements on the digital skin of human
subjects. These observations have led to a significant understanding of the challenges inherent to
skin perfusion measurement and the design specifications that must be met to ensure optimal
sensor reliability. The perfusion measurements obtained from these initial experiments are used
to establish suitable parameters to serve as indicators of vascular reactivity and endothelial
function.
Finally, I will present the design and configuration of a potential sensor housing that addresses
many of the weaknesses in the preliminary sensor measurements. Key efforts will be made
regarding selection of appropriate materials and geometries, analysis of the issues associated
with heat transfer between a surface sensor and the human skin, and appropriate specifications to
implement this within a clinical setting.
Improvements on the methods for determining peripheral blood flow and vascular reactivity may
ultimately contribute to an improved method for assessing cardiovascular risk. Additionally, it is
possible to gain a deeper understanding of the control of skin perfusion with respect to
endothelial function and the role of local vasomotion.
Skin Microvascular Physiology
As the largest organ of the human body, skin takes on a remarkable range of functions and
adaptive mechanisms. It serves as a defensive barrier from environmental stresses and is an
active participant in the body's immune system. Skin also gathers sensory information from the
environment and responds to sensations of touch, pain, heat, and cold. Owing to its position on
the surface of the body and its extensive vascularization, the skin is also a site of active
temperature regulation. The structure of skin is uniquely arranged for its multiple roles and is
comprised of three distinct layers: the epidermis, dermis, and underlying subcutaneous tissue.
The outermost epidermis is avascular stratified epithelium varying in thickness over the body
from 75 to 150 jtm, except on the palms and soles where it is between 400 and 600 gm thick.
The dermis also varies in thickness depending on location - from 4 mm on the back to 2.5 mm
on the thigh to 1.25 mm on the palm [9]. This layer is structurally divided into a superficial
region adjacent to the epidermis called the papillary region and a deep thicker area known as the
reticular region, and it contains the blood vessels, nerves, and specialized cells and structures
such as hair follicles and sweat glands. The subcutaneous tissue is the underlying layer of fat and
connective tissue that contains larger blood vessels and nerves. These features contain the
relevant configuration of blood vessels that are often targeted in microvascular assessments of
the skin. To understand the skin microcirculation within the larger context of the circulatory
system (in health and disease), a description of the major vascular components and regulatory
mechanisms is provided.
2.1 Organization of the Microcirculation
Although the skin is the largest and perhaps the most accessible organ for study on the human
body, scientific knowledge about the structure and organization of the cutaneous circulation has
only been developed in the past three decades. Since then, Irwin Braverman [10] has written
extensively on the organization of the vascular network of human skin. Rather than existing as a
randomly anastomosing network lacking stratification, the skin microcirculation is highly
organized, with two horizontal plexuses: the upper, which lies 1-1.5 mm below the epidermis
with ascending arterial and descending venous limbs (capillary loops) to supply each papilla, and
the lower, which is at the junction between the dermis and the underlying subcutaneous tissue.
The lower (reticular) plexus is formed by perforating vessels from the underlying muscles and
subcutaneous fat (subcutis) and gives rise to arterioles and venules that directly connect with the
upper horizontal (subpapillary) plexus, as well as lateral tributaries that supply the hair bulbs
and sweat glands. These two major networks are contained in the papillary dermis 1 to 2 mm
below the epidermal surface and make up most of the microvasculature. Figure 2.1 depicts the
layers of skin with the corresponding vascular plexuses within each layer.
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Epidermis
Subpapillary
vascular plexus
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Figure 2.1 Layers of skin with microvascular ultrastructure
There are two types of vessels which regulate the terminal blood supply to the skin. The most
numerous are arterioles composed of smooth muscle, which supply capillary beds and are
innervated with sympathetic constrictor fibers. They provide nutrient flow to the skin. Veins
draining these vascular beds comprise large venous networks which provide a large surface area
for heat exchange with the environment. This vascular network is described in more detail in
Sections 2.1.1 to 2.1.3.
The second type of vessel is found in certain skin regions and is composed almost exclusively of
smooth muscle. These vessels, known as arteriovenous anastomoses (AVA), are located in the
subcutaneous plexuses and provide a direct connection between arteries and the venous
networks, bypassing the capillary networks. AVA are especially abundant in exposed areas of
skin with a high surface area to volume ratio, including the pads and nail beds of toes and
fingers, palms, soles of the feet, lips, nose and ears [11] and are important for thermoregulation.
They have a relatively large diameter, on average 35 jtm (20-70 gtm) as compared to capillaries
(5-10 gtm) and are richly (and exclusively) supplied with sympathetic nerve fibers [12]. When
they open, large amounts of blood can pass. Activation of sympathetic nerves leads to active
vasoconstriction, and decrease in sympathetic activity leads to passive vasodilatation. In a
moderately warm environment the AVA are open. In a slightly cold environment, the AVA are
almost closed. Since the capillaries provide the nutritional requirements of the skin, with the
effective capillary area controlled by pre-capillary sphincters, AVA are capable of controlling
capillary blood flow by diverting large volumes of blood through low-resistance pathways. This
type of blood flow is termed non-nutritional flow, or shunt flow.
2.1.1 Arteries & Arterioles
The walls of all arteries are made up of an outer layer of connective tissue, the adventitia; a
middle layer of smooth muscle, the media; and an inner layer, the intima, made up of the
endothelium and underlying connective tissue. The walls of the aorta and other arteries of large
diameter contain a relatively large amount of elastic tissue, primarily located in the inner and
external elastic laminas. They are stretched during systole and recoil on the blood during
diastole. The walls of the arterioles contain less elastic tissue but much more smooth muscle. In
the skin, arterioles appear with venules in the deep vascular plexus and average 17 to 26 gim in
diameter. The arterioles in skin have two layers of smooth muscle cells: the cells of the inner
layer are longitudinally oriented while the cells of the outer layer form a spiral [10]. These
vessels are capable of augmenting microvascular resistance and blood flow distribution in the
skin through dynamic fluctuations in diameter, resulting in blood flow oscillations. The arterioles
are the major site of the resistance to blood flow, and small changes in their caliber cause large
changes in the total peripheral resistance.
2.1.2 Capillaries
Capillaries are small exchange vessels that are fed by terminal arterioles. The openings of the
capillaries are surrounded by precapillary sphincters, which are supplied by sympathetic fibers
from the autonomic nervous system. These fibers maintain a certain basal tone in the sphincters.
In the skin, capillaries have an inner diameter of 4-6 gm. When the sphincters are dilated, the
diameter of the capillaries is just sufficient to permit red blood cells to squeeze through in "single
file." The state of contraction of precapillary sphincters determines the number of perfused
capillaries. Compared to capillaries in other parts of the body in which the vascular wall is
usually only 0.1 gm thick, capillaries in the skin have relatively thick walls, measuring 2-3 jim
[13].
While capillaries lack smooth muscle cells, their walls contain pericytes outside of the
endothelial cells. Pericytes are thinner than smooth muscle cells, have fewer myofilaments, and
lack dense bodies. These cells have long processes that wrap around the vessels. They contain
the contractile proteins necessary for cellular contraction and release a wide variety of vasoactive
agents. Pericytes also synthesize and release constituents of the basement membrane and
extracellular matrix. One of their physiologic functions appears to be regulation of flow through
the junctions between endothelial cells, particularly in the presence of inflammation.
The capillary loop is an important structure in the microcirculation of the skin and supplies the
only nutritional perfusion available to the epidermis. In some cases a capillary loop can be up to
100 gm from the epidermal cells which it supplies. It arises from the terminal arteriole in the
superficial horizontal plexus and is composed of an ascending limb, a hairpin turn, and a
descending limb that returns to the superficial horizontal plexus and connects with the
postcapillary venule. Each dermal papilla is supplied by a single capillary loop which is the
primary site of nutrient and oxygen exchange. Generally, a single capillary loop supplies 0.04-
0.27 mm 2 of the skin surface [14]. Compared to most other tissues, capillary density is relatively
low in skin, ranging from 10 to 70 capillaries/mm 2. At different skin sites, there are no
differences in the ultrastructure of the capillary loops; only density varies.
2.1.3 Venules & Veins
The descending capillary loop feeds into the postcapillary venules, which make up the majority
of vessels in the papillary dermis. The internal diameter enlarges from 8 gm (at venous
capillaries) to 26 gtm and the walls of the venules are only slightly thicker than those of the
capillaries. Blood then passes through the small venules and into systemic veins of increasing
size. Veins have relatively little smooth muscle or elastic tissue and thus are easily distended. In
contrast to small arteries and arterioles, which are resistance vessels, venules and veins function
as capacitance vessels. Pressures within the venous system are low, ranging from 20 mmHg at
the venular ends of capillaries to about 0 mmHg at the entrance to the vena cava. Due to these
properties, the venous system normally contains about 2/3 of the total blood volume, and acts as
a blood reservoir for the body.
2.2 Levels of Blood Flow Regulation
The blood vessels are a closed system of vessels that carry blood from the heart to the tissues and
back to the heart. Figure 2.2 contains a schematic of the various types of vessels in the
circulatory system and their organization in the circulatory network. The resistance to flow
depends mostly on the diameter of the vessels of the microcirculation, principally the arterioles.
The blood flow to each tissue is regulated by local chemical and general neural and humoral
mechanisms that dilate or constrict the vessels of the tissue. A parallel arrangement permits wide
variations in regional blood flow without changing total systemic flow. In humans and other
mammals, multiple cardiovascular regulatory mechanisms have evolved. These mechanisms
increase the blood supply to active tissues and increase or decrease heat loss from the body by
redistributing the blood. In the face of challenges such as hemorrhage, blood flow is maintained
at near constant values in the heart and brain. When the challenge is severe, flow to these vital
organs is maintained at the expense of the circulation to the rest of the body.
At rest, about 67% of the circulating blood volume is in the systemic veins and venules. Five
percent is in the heart cavities, and 12% is in the low-pressure pulmonary circulation. Only 11%
is in the aorta, arteries, and arterioles, and 5% in the capillaries [15]. Although only 5% of the
circulating blood is in the capillaries, this portion is the most vital component of the blood
volume because it is across the systemic capillary walls that 02 and nutrients enter the interstitial
fluid and CO2 and waste products enter the bloodstream. The nutrient exchange across the
capillary walls is essential to the survival of the tissues. Thus, the larger vessels of the body can
be viewed as distinct conduits to and from the heart and peripheral organs whereas the
microcirculatory vessels are embedded within an organ to enhance communication between the
tissue and the vessels.
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Figure 2.2 Vessels of the circulatory system. Blood travels from the heart in arteries, which branch into smaller
and smaller vessels, eventually becoming arterioles. Arterioles connect with still smaller blood vessels called
capillaries. Through the thin walls of the capillaries, oxygen and nutrients pass from blood into tissues, and waste
products pass from tissues into blood. From the capillaries, blood passes into venules, and then into veins to return
to the heart.
The vascular endothelium modulates smooth muscle tone by releasing several vasoactive
substances. The critical role of the endothelium in regulating vasodilator tone was first described
by Furchgott and Zawadzki in 1980 [16]. They demonstrated that the rabbit aorta dilates in
response to the application of acetylcholine only in the presence of intact endothelium,
confirming the existence of an endothelium-derived vasodilator. The principal endothelium-
derived relaxing factor (EDRF) was later confirmed to be nitric oxide (NO) [17, 18], and
numerous subsequent studies have explored the multiple vascular functions of this simple,
diatomic molecule, confirming its role as a central signal transducer and essential antiatherogenic
molecule. It is released during basal conditions in response to chemical stimuli, such as
acetylcholine (ACh), and in response to mechanical stimuli, such as shear stress.
Endothelial cells also generate several other vasoactive mediators, including the vasodilator
molecules prostacyclin and endothelium-derived hyperpolarizing factor (EDHF), and the
vasoconstrictor agents endothelin-1, angiotensin II, superoxide anions, and vasoconstrictor
prostanoids. The development of an imbalance in the release of vasoconstrictor and vasodilator
agents from the endothelium leads to an impairment of endothelium-dependent vasodilatation,
which represents the hallmark of endothelial dysfunction [19]. In parallel with the vasomotor
changes, activated dysfunctional endothelial cells also acquire a vascular phenotype that
establishes a local environment favoring the initiation and progression of atherosclerosis [20].
This area of blood flow regulation will be addressed more thoroughly with regard to endothelial
dysfunction in Section 3.1.
2.3 Skin Blood Flow: Roles in Tissue Nutrition and Thermoregulation
The skin is both a protective barrier and an important thermoregulatory organ. As a result, it has
an extensive and well-developed microcirculation. Human skin microcirculation serves three
main functions, namely skin tissue nutrition, heat exchange for thermoregulation, and blood flow
redistribution during stress. While the oxygen and nutrient requirements of the skin are small and
thus little blood flow is necessary to sustain nutritional perfusion, the skin is the primary means
of maintaining body temperature. To meet these needs, skin blood flow can vary between less
than 1 ml/min per 100 g of tissue to a maximal flow of 150 to 200 ml/min- 100g during times of
severe heat stress (up to 60% of total cardiac output) [21]. In a thermoneutral environment, skin
blood flow ranges between 10 and 20 ml/min- 100g [22]. This impressive range of possible
circulatory states is achieved through a balance of neural and local control mechanisms that
precisely modulate the vasomotor tone and vascular resistance of the peripheral microcirculation.
In particular, thermoregulatory control is largely mediated through reflex neural control of skin
blood flow.
Skin blood flow is controlled by two branches of the sympathetic nervous system: a
noradrenergic vasoconstrictor system and an active vasodilator system, which is less well-
understood. While both types of nerves innervate all areas of non-acral skin (trunk, leg, forearm,
etc.), areas of acral skin (lips, ears, nose, palmar/plantar surface of hands and feet) are innervated
only by sympathetic vasoconstrictor nerves [21]. In thermoneutral environments, the
vasoconstrictor system is tonically active such that withdrawal of the impulses to these nerve
fibers allows blood vessels to dilate. This allows for a "neutral" or "vasomotor" zone of
thermoregulation where the skin responds to subtle changes in the environment by fine-tuning
heat loss solely via adjustments in sympathetic tone [23]. In skin areas outside of acral regions,
an active sympathetic vasodilation system exists which is inactive in thermoneutral
environments, but is activated during increases in internal temperature. Therefore, as core body
temperature begins to rise (such as during exercise or environmental heat exposure), the initial
increase in skin blood flow is mediated by release of vasoconstrictor tone. However, upon
reaching a specific threshold, sweating and reflex active vasodilatation are initiated in tandem,
stimulating the co-release of acetylcholine (ACh) and an associated yet-unknown vasodilator
from sympathetic cholinergic nerves [21]. The active vasodilator system is responsible for 80%-
90% of the large increases in skin blood flow during heat stress, which can reach levels as high
as 6-8 L/min.
As was discussed in Section 2.1, numerous arteriovenous anastomoses (AVA) exist in acral skin.
These thick-walled, low-resistance conduits are richly innervated by sympathetic vasoconstrictor
nerves and allow high rates of shunt flow between arterioles and venules. Therefore, in acral
areas, opening or closing of these AVA can cause substantial changes in the blood volume that
passes through the skin. Sympathetic input to AVA is controlled from hypothalamic temperature
regulation centers, while cutaneous arterioles are primarily controlled by neural activity, with
local metabolic control secondary.
The periodic oscillations recorded in cutaneous blood flow reflect both vasomotion and flow
motion and have been quantified by spectral analysis of the laser Doppler perfusion signal [24].
Vasomotion is defined as the rhythmic changes in the diameter of small blood vessels and is
produced by contraction and relaxation of the muscular components in their walls. An important
component of vasomotion in skin includes the myogenic activity of terminal arterioles as well as
endogenous endothelial activity, such that not all skin microvascular units are open and perfused
at any moment in time. Flow motion results from the motion of the blood cells and their
interaction with the vessel walls and is dependent on the different vasomotor control
mechanisms. The characteristic oscillation frequencies present in skin flow motion include a
cardiac component (-1 Hz in a resting, healthy subject) and respiratory component (-0.3 Hz),
which demonstrate the dependence of peripheral blood flow on the pressure difference generated
by the heart and lung pumps. There are also contributions from intrinsic myogenic activity of the
vessel wall (0.1 Hz) and neurogenic activity of the local sympathetic nerves (0.03 Hz) [25]. An
oscillation with a period of around 1 min (-0.01 Hz) has been suggested as being endothelium-
dependent and may reflect either periodic release of NO or the rhythmic response to NO of an
oscillator in vascular smooth muscle cells [26].
2.4 Reactive Hyperemia
If arterial inflow to a vascular bed is stopped temporarily, perfusion within that bed decreases to
zero. Upon release of the occlusion, the blood flow immediately exceeds the average flow before
occlusion and then gradually returns to the baseline level. This increase in flow is called reactive
hyperemia. The peak flow and duration of the reactive hyperemia are relatively proportional to
the duration of the occlusion within certain limits. If the extremity is exercised during the
occlusion period, reactive hyperemia is increased. These suggest a locally mediated mechanism,
either metabolic or otherwise, in the regulation of tissue blood flow.
Post-occlusive skin reactive hyperemia has been primarily defined in laser Doppler flowmetry
studies of skin perfusion flux and refers to the increase in skin blood flow above baseline levels
following the release of a brief arterial occlusion. It is also called post-ischemic hyperemia. It
can be characterized by an initial peak in flux (perfusion) that occurs within a few seconds of
removal of the occlusion, and a sustained hyperemia. Four major factors have been proposed to
be involved in the hyperemic response: metabolic vasodilators, endothelial vasodilators, the
myogenic response and sensory nerves. The post-ischemic peak flow reflects the sudden increase
of the blood flow in the skin microvessels after removal of the occlusion and can be considered
an indicator of the increased shear stress on the microvascular wall. The more prolonged
hyperemic phase reflects the metabolic debt repayment to the tissue [27] and can be considered
as an indicator of successive tissue reperfusion.
Unlike flow-mediated dilatation, reactive hyperemia is a complex response that depends on the
local production of non-endothelium-dependent vasodilators which dilate tissue microvessels to
accelerate the delivery of oxygen following a period of ischemia [28]. Endothelium-derived
nitric oxide plays a role in reactive hyperemia as well [29, 30]. Despite the similarities in
procedure and vascular regions, it is now thought that reactive hyperemia proceeds through
different mechanisms compared to conduit artery flow-mediated dilatation (FMD). This topic
will be addressed more fully in Section 3.2.
2.5 Skin Microcirculation in Health and Disease
The microcirculation is of interest because it is where fine control of blood supply takes place,
and tissue ischemia is dependent on microvascular flow in many circumstances. During
circulatory failure (e.g. hypovolemic shock), blood flow is diverted from the less important
tissues (skin, subcutaneous fat, muscle, large intestine) to vital organs (heart, brain, kidneys).
Thus monitoring perfusion in the less vital tissues such as skin could be an early clinical marker
of critical tissue hypoperfusion. Indeed, the assessment of perfusion in peripheral tissues is more
easily obtainable using noninvasive monitoring techniques, thus facilitating earlier recognition of
abnormalities. The skin can provide a good platform for this, and in diabetes, for example,
measurable changes in the skin have been found to pre-date the symptoms of microvascular
disease in other organs by many years [31]. In the dermal microcirculation, endothelial function
may be assessed noninvasively using several methods, although no one technique is entirely
satisfactory. Nevertheless, this vascular bed is highly suitable for assessment of the endothelium,
and is particularly convenient.
By posing the dermal microcirculation as a way to interrogate overall vascular health, it is
important to recognize that cutaneous blood flow is a dynamically fluctuating biological variable
which possesses substantial spatial heterogeneity. Its magnitude and regulation is modulated
through many external and internal parameters by virtue of its central role in thermoregulation
and tissue perfusion. Microcirculatory flow adjusts as a result of variations in blood gas
concentration, hormones, and physical factors like temperature and pressure. It is also carefully
controlled by the autonomous nervous system. Such signals increase or decrease the
microvascular perfusion by stimulating the endothelium to release substances leading to
vasoconstriction or vasodilatation of the upstream arterioles. Characterizing these systemic
regulators of blood flow also impacts current understanding of perfusion. Several important
clinical goals arise from these local and global relationships. Not only is the status of a patient's
generalized microvasculature important, but direct associations must be determined to provide
information as it relates to underlying pathophysiology.
Chapter 3. Endothelial Dysfunction & Methods of Assessment
3.1 Pathophysiology of Endothelial Dysfunction
The normal endothelium plays a key role in the local regulation of vascular tone by producing
and secreting substances within a region of the vascular bed. To maintain vascular homeostasis,
healthy endothelial cells perform a variety of functions [32] (Figure 3.1):
* Promote vasodilation
* Antioxidant effects
* Anti-inflammatory effects
* Inhibition of leukocyte adhesion and migration
* Inhibition of smooth muscle cell (SMC) proliferation and migration
* Inhibition of platelet aggregation and adhesion
* Anticoagulant effects
* Profibrinolytic effects
Vasodilation
Thrombolysis
Platelet disaggregation Vasoconstriction
Antiproliferation Thrombosis
AntiinflammationA tiinfla matio  Adhesion moleculesAntioxidant Growth factors
Inflammation
Oxidant activity
Figure 3.1 Regulatory functions of the endothelium. Healthy endothelium protects the vessels from
atherosclerosis. Dysfunctional endothelium possesses proatherogenic properties, shifting the balance towards
vasoconstriction, thrombosis, inflammation, and ultimately atherogenesis. [33]
Normal endothelial cells promote an antiatherogenic vessel phenotype and are capable of
maintaining a delicate balance between local and systemic stimuli. However, when endothelial
cells lose this ability, the resulting imbalance leads to a state of endothelial "activation," which is
characterized by abnormal vasomotor function in addition to a proinflammatory, proliferative,
and prothrombotic state that favors the initiation and progression of atherosclerosis [1]. Although
the precise mechanisms that cause endothelial dysfunction are not fully understood, it is thought
to be a multifactorial process involving mechanical or biochemical damage to endothelial cells
and the loss of appropriate response to certain stimuli. One possible mechanism relates to the
increased production of reactive oxygen species, such as superoxide, which have been shown to
reduce endothelial nitric oxide availability via multiple pathways [34]. Furthermore,
cardiovascular risk factors are known to activate a number of pro-oxidative genes in the vascular
wall. In fact, increased vascular superoxide production has been demonstrated in all major
conditions predisposing to atherosclerosis [35].
Endothelial dysfunction is most effectively defined by the diminished production or
bioavailability of vasodilators (e..g. nitric oxide, or NO) or an increase in endothelium-derived
contracting factors, leading to impaired endothelium-dependent vasodilatation [36]. This can be
assessed functionally by a measure of abnormal vasoreactivity (response to pharmacological or
physiological stimulation). However, it is the positive feedback loop in which inflammatory
factors promote monocyte and T-cell adhesion, foam cell formation, extracellular matrix
digestion, and vascular smooth muscle migration and proliferation that ultimately leads to
atherosclerotic plaque formation. This can include multiple mechanisms, such as up-regulation
of adhesion molecules, increased chemokine secretion and leukocyte adherence, increased cell
permeability, enhanced low-density lipoprotein (LDL) oxidation, platelet activation, cytokine
elaboration, and vascular smooth muscle cell proliferation and migration [33]. The host defense
response is triggered, allowing the endothelium to be invaded by lipids and leukocytes and
inciting an inflammatory response within the vessel wall. Fatty streaks appear and develop into
plaques that are susceptible to rupture with subsequent thrombogenesis and vascular occlusion
[33].
Given the relationship between endothelial dysfunction and atherosclerosis, it is likely that the
status of an individual's endothelial function reflects their susceptibility to develop
atherosclerotic disease and may thus serve as a marker of an unfavorable cardiovascular
prognosis. Both novel and conventional cardiovascular risk factors are associated with abnormal
endothelial function and may influence the bioavailability of endothelial NO or lead to a state of
endothelial activation. For example, hypertension, chronic heart failure, diabetes,
hypercholesterolemia, smoking, aging, and a family history of premature atherosclerotic disease
are all associated with impaired endothelium-mediated vasodilatation. Table 3.1 summarizes
many of the established and recent conditions that have been associated with endothelial
dysfunction.
Furthermore, many interventions that are known to limit cardiovascular risk have been shown to
restore endothelial function. Thus, endothelial dysfunction is a reversible disorder, and strategies
aimed at reducing cardiovascular risk factors, such as cholesterol lowering [37], antihypertensive
therapy [38], smoking cessation [39], estrogen replacement therapy in postmenopausal women
[40], supplementation with folic acid [41], and physical exercise [42] also translate into an
improvement in endothelial health, further supporting the association between risk factors and
endothelial dysfunction. Moreover, the observation that several pharmacological interventions
that improve endothelial function are associated with a decrease in cardiovascular events
independent of risk factor modification supports the concept that cardiovascular risk factors
share a common pathway that leads to endothelial dysfunction, such as oxidative stress. A
Medline search reveals that several hundred articles are published every year on the role of
different therapeutic interventions aimed at influencing endothelial function. It is clear that
evaluation of endothelial function in humans is of great clinical relevance.
Table 3.1 Factors associated with endothelial dysfunction in the literature and investigated therapies that
improve endothelial dysfunction
Factors related to Factors improvingReferences References
endothelial dysfunction endothelial function
Angiotensin-converting
Age [43-46] [38, 47, 48]
enzyme inhibitors
Male sex [43] Hormone-replacement [40, 49, 50]
Smoking [3, 39, 51, 52] Smoking cessation [39, 53]
Passive Smoking [54, 55] Exercise [42, 56-58]
Diabetes mellitus: [59-62] L-Arginine [53, 63]
Types 1 and 2
Hyperglycemia [64] Calcium channel blockers [65, 66]
Family History of CAD [67, 68] Statin therapy [69-74]
Hypertension [52, 75-77] LDL apheresis [78]
High cholesterol [79-82] Antioxidants [83-85]
Low HDL [67, 86] Homocysteine lowering [87, 88]
Obesity [89, 90] Weight loss [91]
Heart failure [92-94] Omega-3 Fatty Acids [95]
Hyperhomocysteinemia [96, 97] Aspirin [98]
End-Stage Renal Disease [99, 100]
Elevated C-reactive protein [101]
Chronic Systemic
inflammation [102]
Given the endothelium's unique position as both the mechanical and biological barrier between
blood and the vascular wall, endothelial function represents an integrated index of overall
cardiovascular risk factors and local factors (e.g. shear stress), genetic predisposition, and yet-
unknown factors (protective and harmful) that confer individual susceptibility to developing
atherosclerotic disease as well as predisposition to the subsequent acute complications (Figure
3.2). Indeed, some investigators consider endothelial dysfunction to be the "risk of risk factors"
[32]. Therefore, the status of endothelial function offers unparalleled potential for improved risk
stratification, as well as the possibility of targeted therapies and prognosis.
Genetic
Predisposition
Traditional/Non-traditional
Risk Factors
Atherogenesis and Complications
(Myocardial Infarction, Stroke, PAD, Heart Failure)
Figure 3.2 Endothelial dysfunction as an index of overall cardiovascular risk
3.2 Systemic Impact of Endothelial Dysfunction and Atherosclerosis
Because atherosclerosis is a generalized macrovascular disease, lesions in one vascular territory
predict disease in other arterial regions. This systemic nature was documented by the
Framingham study which showed that patients first presenting with myocardial infarction,
cerebral vascular accident, heart failure, or peripheral vascular insufficiency would, in the
following 10 years, manifest disease in another vascular territory in proportions varying from
16% to 50%, both for men and women [104]. Similar risk factors are present among patients
with coronary, peripheral, and carotid atherosclerosis. Of particular importance is evidence that
disease in noncoronary arteries is a powerful predictor of coronary heart disease (CHD)
mortality. Aortic, peripheral, and carotid artery diseases have been termed "Coronary Heart
Disease Equivalents" because the level of CHD risk and CHD event rates associated with these
conditions is approximately equivalent to the level of risk seen in stable CHD. That is, the rate of
CHD events in persons with atherosclerotic vascular disease in other territories is similar to event
rates in patients with known CHD. Additionally, macro- and micro-vascular disease are the
principle causes of morbidity and mortality in patients with diabetes mellitus, which is, by itself,
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a powerful predictor for CHD, stroke, and peripheral arterial disease. In fact, diabetes is also
known as a CHD risk equivalent.
Endothelial dysfunction thus appears to be a systemic phenomenon, affecting resistance and
conduit vessels in the extremities as well as the coronary circulation [105]. Systemic endothelial
dysfunction is often found to be reflected in the peripheral circulation such that macrovascular
and microvascular abnormalities share common functional characteristics. There has been a
demonstrated correlation between brachial artery reactivity (flow-mediated dilatation) and
coronary artery response to intracoronary infusion of vasoactive substances [106, 107],
suggesting that the vascular endothelium exhibits systemic characteristics. Furthermore, as with
the coronary circulation, peripheral vasomotor function is diminished in subjects at risk for
atherosclerosis, and medical interventions and lifestyle changes that reduce atherosclerotic risk
are also associated with improved peripheral vascular function. The correlation in endothelial
function in both the coronary and the peripheral vasculature suggests that a common pathway
contributes to endothelial dysfunction in both vascular beds. Therefore, the peripheral vascular
bed may be used as a surrogate for assessing endothelial function in the coronary arteries,
minimizing the invasive nature of coronary investigations.
There is growing evidence that microvascular disease plays a prominent role in the pathogenesis
of vascular diseases and mortality [108]. There is also increasing evidence that coronary
microvascular dysfunction may be one underlying mechanism in patients with symptoms and
signs of myocardial ischemia without angiographically detectable coronary artery disease, and
even in asymptomatic patients with cardiovascular risk factors [109, 110]. Microvascular
processes, primarily in the coronary microcirculation, have also been implicated in left
ventricular dysfunction and subsequent heart failure, particularly in people with diabetes and
hypertension, as well as in patients with dilated or hypertrophic cardiomyopathy. However, the
majority of these studies have been cross-sectional and have focused on small samples of highly
selected symptomatic patients. In addition, since the coronary circulation cannot be visualized in
vivo and methods to assess the coronary microcirculation are invasive and applicable only in
experimental settings, what is known about microvascular mechanisms in the pathogenesis of
congestive heart failure has been derived indirectly from studies of functional parameters such as
myocardial blood flow and coronary flow reserve.
Several studies have suggested that microcirculation in the skin resembles the microcirculation in
other tissues and could be used to mirror the state of the microcirculation in other vascular beds
to gauge overall cardiovascular health. Furthermore, the skin is highly vascular and an easily
accessible model of the microcirculation. Therefore, skin microcirculation offers an opportunity
to noninvasively explore the relation of systemic microvascular dysfunction to cardiovascular
disease and its risk factors [111].
For example, in individuals with hypertension, microvascular defects can be demonstrated in
heart, skeletal muscle and skin. Similarly, an association of diabetes and insulin resistance with
microvascular function has been reported in heart, skeletal muscle and skin tissue [112]. Not
only have the metabolic and vascular effects of insulin been demonstrated in skin [113, 114],
several studies have demonstrated that impaired microvascular reactivity in the skin are
associated with elevated blood pressure and insulin resistance [111, 115-118]. Impairment of
post-ischemic reactive hyperemia as measured by laser Doppler signal in forearm skin has also
been associated with increased heart disease risk according to the Framingham risk score [119].
These studies suggest that microvascular function in the skin resembles microvascular function
in other tissues, particularly with regard to functional deficits related to disease. Additional
support comes from studies demonstrating that impaired responses of the skin microcirculation
may be reversed after cholesterol-lowering therapy [70, 120, 121]. These findings suggest that
microvascular function in skin may be a valid model for the study of the relationships between
cardiovascular risk factors and vascular function. What's more, individuals at an increased risk
for cardiovascular disease can be characterized by impaired microvascular function in skin.
It is nevertheless important to note that the relationship between the commonly assessed brachial
FMD does not clearly correspond to the magnitude of skin reactive hyperemia [122, 123], and
there seems to be uncertainty regarding the relationship between conduit artery function and
downstream peripheral perfusion. While some investigators have found a correlation between the
two [123, 124], others have shown no correlation between conduit artery reactivity (FMD) and
microvascular vasomotion (LDF perfusion) [122, 125]. In one such study showing no
correlation, it was found that laser Doppler-derived indices during reactive hyperemia were
actually more specific for diagnosis of coronary artery disease than measurement of brachial
FMD [122]. Thus, further research must investigate the possibility of different vasodilatory
mechanisms or factors that would account for this lack of correlation between conduit vessels
and the cutaneous microcirculation.
A notable finding in the vasodilatory mechanism of skin microvascular reactivity has revealed
that different mechanisms of endothelium-dependent responses vary among different vascular
beds. It was established that brachial artery reactivity is principally mediated through
endothelium-dependent release of nitric oxide [126]. However, reactivity of skin microvessels
has been demonstrated to be largely nitric oxide-independent [127], although it has also been
shown to play a role [29, 30]. Instead, skin reactive hyperemia appears to be principally
regulated by endothelial release of prostaglandins (vasodilators) [71] as well as endothelium-
independent factors induced by ischemia such as adenosine, pH, pO2, and myogenic control
[125]. This is an important consideration when interpreting data from different techniques
employing tests of reactive hyperemia as skin perfusion reactivity may or may not be an
endothelium-dependent response.
Kullo et al. [52] suggest that reactive hyperemia is primarily a microvascular response to
transient ischemia and involves the local release of ischemia-induced vasodilator substances
from resistance vessels, although a portion of the hyperemic response may be endothelium-
dependent. FMD, on the other hand, is mainly dependent on the release of the vasodilator NO
from the conduit artery endothelium. Their relationship can be most understood when
considering a test of reactive hyperemia: In healthy endothelium, an occlusion of the conduit
artery induces release of vasodilators from the microvasculature. When occlusion is released, the
reduced microvascular resistance results in increased conduit artery and flow, causing shear
stress to the endothelium and culminating in vasodilatation of the conduit artery mainly via nitric
oxide.
Thus, reactive hyperemia and FMD, although interrelated, may represent different vascular
phenotypes, and these two measures may provide additive rather than redundant information
about vascular alterations in tests of endothelial dysfunction. It appears that both microvascular
and conduit artery function are independently impaired in the presence of coexisting CV risk
factors, and different mechanisms may be involved in the development of microvascular versus
conduit artery dysfunction. In a recent prospective study by Huang et al. [128], investigators
acknowledged the different mechanisms underlying each stimulus and showed that both flow-
mediated dilatation and reactive hyperemia were significant predictors of cardiovascular risk.
Furthermore, a lower hyperemic flow velocity (a measure of microvascular function) predicted
cardiovascular events in a high risk group of patients with peripheral arterial disease referred for
surgery.
3.3 Techniques for the Assessment of Endothelial Dysfunction
Endothelial dysfunction is the loss or reduction of the endothelium's capacity to defend against
proatherogenic factors. It is evaluated by assessing the reactivity of the endothelium, either
directly or indirectly.
3.3.1 Intracoronary Studies
The first experiments to evaluate endothelium-dependent vasodilatation were performed by
invasive catheterization of atherosclerotic epicardial coronary arteries in 1986 [129]. Drugs that
induced NO release were injected, such as acetylcholine, metacholine, papaverine, P substance,
etc., and the percentage of vasodilatation was measured. Ludmer et al. [129] found that injecting
acetylcholine in normal coronary arteries produced endothelium-dependent vasodilatation,
whereas in coronary arteries with moderate or severe atherosclerotic lesions a paradoxical
vasoconstriction was obtained, indicating that endothelial dysfunction was present. The
paradoxical vasoconstriction is due to stimulation of the muscarinic receptors of the smooth
muscle cells by direct acetylcholine action. It was also found that after injecting nitroglycerine,
an NO donor and direct smooth muscle dilator, there was always vasodilatation (endothelium-
independent). This preserved response to the direct smooth muscle vasodilator further suggests
disturbances of endothelial origin. Using the same method, Vita et al. [130] found that the
amount of coronary vasodilatation obtained by acetylcholine diminished inversely with the
increase of total cholesterol or LDL-cholesterol levels. They also observed that the presence of
multiple cardiovascular risk factors was associated with a greater constrictor response to
acetylcholine, evidencing the additive effects on endothelial dysfunction.
Noninvasive assessment of coronary endothelial function is also possible through Doppler
echocardiography, positron emission tomography (PET) and phase-constrast magnetic resonance
imaging (MRI). However, the invasive assessment of coronary endothelial function by
quantitative coronary angiography and coronary Doppler flow measurements, in conjunction
with intracoronary infusions of endothelium-dependent vasodilators, such as acetylcholine, is
considered the "gold standard" for endothelial function testing.
To measure endothelial dysfunction in peripheral vascular beds, less invasive techniques have
been developed, such as strain-gauge forearm plethysmography and high-resolution ultrasound
to measure flow-mediated endothelium-dependent vasodilatation of the brachial artery during
reactive hyperemia. These techniques are based on the previously discussed view that endothelial
dysfunction is not confined to the coronary arteries but rather represents a systemic disorder that
also affects peripheral vascular beds, including both conduit arteries and small resistance vessels
in the extremities.
3.3.2 Strain-Gauge Venous Occlusion Plethysmography (VOP)
Studies seeking a noninvasive way to investigate endothelial dysfunction have focused on
reactivity of peripheral resistance arteries using forearm plethysmography. This technique,
known as venous occlusion plethysmography (VOP), is an established method of measuring total
blood flow and vascular resistance in either the upper or lower limb with a strain gauge that has
been tied around the limb of interest. With this technique, measurements in the forearm vascular
bed have demonstrated the significance of microvascular resistance artery endothelial
dysfunction in essential hypertension [75-77, 131, 132], diabetes [133], dyslipidemia [81], heart
failure [134, 135], coronary artery disease [136], and smoking [137]. Most of these
investigations were semi-invasive since they demonstrated endothelial function by drug infusions
into the brachial artery.
The basic methodology of forearm venous occlusion plethysmography involves an interruption
in venous return from the forearm by inflating a cuff, placed around the upper arm, to well above
venous pressure but below diastolic pressure (30-40 mmHg). Arterial inflow is unaltered and
causes forearm volume to increase over time, until the venous pressure overcomes the occluding
pressure. Typically, the cuff is inflated for intervals of 10 seconds, followed by 5 seconds of
deflation to allow for venous emptying, resulting in linear increases in forearm volume over
time, which are proportional to the arterial inflow [138] (Figure 3.3). Hand blood flow is
excluded from measurement due to its high level of temperature-dependence (arteriovenous
anastomoses) and nonlinear contribution to the measurement [139]. It is standard practice to
inflate a smaller cuff around the wrist to a suprasystolic pressure about 60 seconds before
starting measurement. Since the hand becomes ischemic, measurement periods are limited, but
periods of up to 13 minutes have been employed safely [140].
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Figure 3.3 Venous Occlusion Plethysmography (VOP) measures the changes in blood volume within a limb
during short periods of venous occlusion.
Changes in limb volume during forearm blood flow (FBF) measurements are assessed by a
plethysmograph. Calibrated mercury-in-silastic strain gauges (or indium-gallium gauges) are
placed around the widest part of the forearm. When the forearm volume changes, a
corresponding change in the circumference of the arm occurs, thereby altering the strain gauge
length and the electrical resistance of the gauge. Thus, changes in limb volume are directly
related to changes in gauge resistance, providing a measure of blood flow to the enclosed volume
of the forearm, assuming a cylindrical shape [141]. This is usually expressed as ml per 100 ml of
forearm volume per minute. Technical advances in this method include computer control and the
use of an electro-mechanical sensor with automated calibration instead of the conventional strain
gauge.
Venous occlusion plethysmography can also be used to observe flow changes following a period
of ischemia, such as with post-occlusion reactive hyperemia. In this test, an arterial cuff is placed
proximal to the venous occlusion cuff and plethysmograph. After establishing a baseline flow,
the arterial occlusion cuff is inflated to a suprasystolic pressure for 3-5 minutes and the resulting
flow following release of the cuff is recorded.
Although VOP is a widely-used method of measuring forearm blood flow, it is technically
challenging, especially during reactive hyperemia. It has been most useful when coupled with
intra-arterial drug infusion, which, due to its invasive nature, has limited its application and
reliability. For example, this technique is not appropriate for applications that require
investigators to distinguish between skin and muscle blood flow, which account for roughly 30%
and 70% of resting blood flow in the forearm [139]. Also, VOP provides only discontinuous
measurements, taken every 10-15 seconds. However, the data obtained from studies measuring
FBF support the concept of measuring flow, or flow and shear rate-dependent parameters during
the hyperemic response, to investigate the integrity of endothelium-dependent vascular
reactivity.
3.3.3 Brachial Artery Ultrasound Measurement of Endothelium-Dependent
Flow-Mediated Dilatation (FMD)
In 1992, Celermajer et al. [67] evaluated flow-mediated vasodilatation (FMD) of the brachial
artery, an endothelium-dependent function, by high-resolution ultrasound imaging. In this study,
investigators found evidence of endothelial dysfunction, characterized by diminished FMD, in
individuals at risk for atherosclerosis. Also known as the reactive hyperemia test, this technique
is now widely used in basic science and clinical research. Because of the ease with which it can
be done and its reliability, endothelium-dependent FMD is considered to be the gold standard in
noninvasive endothelial function assessment [33]. Figure 3.4 displays typical ultrasound
measurements taken on the brachial artery during a test of reactive hyperemia.
A.
Figure 3.4 Brachial artery ultrasonography and endothelial function testing. Brachial artery ultrasonography
has been used to evaluate endothelial function noninvasively by measuring vascular reactivity to increases in flow-
induced shear stress, a NO-mediated event. This method has been shown to correlate with coronary vasodilator
responses. (A) Baseline brachial artery ultrasound image (top) with corresponding flow velocities (bottom). (B)
Reactive hyperemia induces flow-mediated vasodilatation of the brachial artery (top) that is accompanied by
increased flow velocities in the artery (bottom).
In a typical FMD measurement, forearm or hand ischemia is induced and maintained for 5
minutes by interrupting arterial blood supply with a blood pressure cuff inflated to suprasystolic
pressure. When the pressure is released, reactive hyperemia occurs caused by dilation of the
distal microvasculature. The reactive hyperemic response can be characterized by two distinct
phases: a maximal, or peak, response that occurs within a few seconds after removal of the
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occlusion and a more prolonged total hyperemic period that is thought to represent the blood
flow debt repayment. This capacity of blood vessels to respond to physical and chemical stimuli
in the lumen confers the ability to self-regulate tone and to adjust blood flow and distribution in
response to changes in the local environment. Many blood vessels respond to an increase in flow,
or more precisely shear stress, by dilating (lowering the vascular resistance). This phenomenon is
designated FMD and is thought to be principally mediated by endothelium-derived nitric oxide
(NO).
Theory suggests that shear stress and alterations in hydrostatic pressure during reactive
hyperemia result in the local release of NO with subsequent vasodilatation that can be imaged
and quantitated by ultrasound. By creating a shear stress stimulus that produces an NO-
dependent response, the FMD measurements can be used as an assay of NO bioavailability (a
combination of NO production by the endothelium and destruction by reactive oxygen species).
In this case, NO is of particular interest to researchers as it is an antiatherogenic molecule, and a
reduction in its bioavailability may play a role in the pathogenesis of vascular disease [142]. A
small FMD response is interpreted as indicating a low NO bioavailability and possibly an
associated increased risk of vascular disease or cardiac events. In humans FMD is typically
assessed in the large peripheral conduit arteries (brachial, radial and femoral) and is often taken
to represent the response in the more clinically relevant coronary circulation [106].
Despite widespread use in clinical research and ongoing attempts to standardize FMD protocol,
the methods being used for the noninvasive assessment of peripheral endothelial function differ
greatly between laboratories [143]. For example, some investigators place the occluding cuff
above the elbow, whereas others place it below the elbow [144]. The time after cuff deflation
when measurements are taken also varies between laboratories [145]. These are important areas
of further standardization, especially for investigators who hope to evaluate conduit artery
endothelial function in a consistent and reliable manner. Under specific flow conditions in the
brachial artery, dilatation has been shown to be a primarily NO-dependent FMD response [126]
although later evidence reveals that certain shear stress stimulus profiles (e.g. sustained
hyperemia) elicit mechanisms primarily independent of NO [80]. Different occlusion durations,
cuff positions, degrees of ischemic dilatation (with the addition of an ischemic forearm exercise)
or areas of the circulation examined (upper versus lower limb) result in distinct shear stress
profiles created upon occlusion release [144]. This suggests that there are multiple mechanisms
involved in FMD and that the mechanisms involved in any given response are highly sensitive to
the nature of the stimulus imposed (stimulus-response specificity).
Unfortunately, current studies frequently do not address the conditions that are required to evoke
a reliable NO-dependent FMD response. The high cost of an ultrasound imaging device and the
need for a skilled operator further limit the technique's utility in a clinical setting. Finally, there
is considerable operator dependence in several aspects of how the test is performed and the
results can have up to 25% day-to-day variability [19]. Therefore, this tool is limited in clinical
utility until standard methodology is developed that will provide more consistency for
longitudinal follow-up and allow comparisons of data from various laboratories.
Despite the disadvantages posed by lack of standardization, brachial FMD measurement is one of
the few noninvasive techniques that can measure peripheral endothelial dysfunction, even in
subjects as young as 5 years of age [68]. This technique is attractive because it is safe and allows
repeated measurements. Furthermore, brachial artery reactivity has been shown to accurately
reflect coronary reactivity and therefore can be used as a surrogate marker of coronary
endothelial function [106]. This observation is based on the principle that endothelial
dysfunction actually precedes clinical manifestations of coronary artery disease and is thus a
better prognostic indicator of events than coronary lesions themselves. In contrast, other
modalities are more invasive and largely provide information about the presence and severity of
fixed anatomic disease, which may be less relevant to the pathogenesis of events. FMD is
associated with several risk factors and can be improved by the correction of many classic risk
factors such as hypercholesterolemia and arterial hypertension [143].
3.4 Current Methods for Noninvasive Evaluation of the Microcirculation
The ability to evaluate the microvascular structure and function is important for an understanding
of pathophysiological processes in multiple disease states. A range of techniques are available or
emerging for investigating different aspects of the microcirculation in humans. Techniques such
as orthogonal polarization spectral imaging allow visualization at the level of single
microvessels. Venous occlusion plethysmography can be used to measure regional blood flow in
organs and limbs, and laser Doppler flowmetry to measure red blood cell flux in small areas of
tissue. A variety of thermal methods have been proposed as well and are discussed in Section
3.5.
3.4.1 Laser Doppler Flowmetry
Laser Doppler flowmetry (LDF) is a noninvasive, continuous measure of microcirculatory blood
flow and has been used to measure microcirculatory blood flow in many tissues including neural,
muscle, skin, bone, and intestine. The principle of this measurement is the Doppler shift, or the
frequency change that light undergoes when reflected by moving objects - in this case: red blood
cells (Figure 3.5). A sample volume of the tissue under observation is illuminated with
monochromatic laser light from a probe. When the tissue is illuminated, only 3-7% is reflected.
The remaining 93-97% of the light is either absorbed by various structures or undergoes
scattering due to interactions with static and moving cells [146]. Photons scattered on blood cells
are frequency-shifted (Doppler effect) proportional to the speed of the moving cells. Another
optical fiber collects the backscattered light from the tissue and returns it to the monitor. After
the signal is amplified and analyzed, LDF produces an analog output signal that is proportional
to the number of blood cells multiplied by the mean velocity of these cells, or the blood cell
perfusion (flux).
Figure 3.5 Basic operating principles of laser Doppler flowmetry (LDF). Laser light is directed at an area of
tissue where it is reflected and scattered by red blood cells within the tissue, resulting in frequency-shifted light
which is detected and received by a photodetector.
As a noninvasive measure of peripheral blood flow, LDF is often designed with a fiber optic
probe separation of 500 gm between the transmitting and receiving fibers. When applied to the
skin, this results in a penetration depth of about 1.0-1.5 mm and an interrogated volume of
approximately 1 mm3 [10]. Therefore, it can be assumed that flow is measured in arterioles,
venules, arteriovenous anastomoses, and, to a much smaller extent, nutritional capillaries (about
5%). Indeed, evidence suggests that the dominant part of the LDF signal is generated by
movement of blood cells in the subpapillary vascular bed of the skin while only a small portion
is due to motion of blood cells in the nutritional capillaries [ 147]. However, the relative
distribution of blood between non-nutritional, subpapillary vascular beds and nutritional
papillary capillaries in the skin differs markedly across skin regions, making interpretation of
results difficult in some cases. The measuring depth and volume of LDF on skin is also
influenced by multiple factors, e.g. the amount of blood and the composition of skin, and
decreases in sensitivity in relation to the depth in the dermis.
LDF has been applied to obtain information on the functional state of the skin microcirculation
during either reactive hyperemia following ischemia or the noninvasive local application of
acetylcholine or sodium nitroprusside in several conditions. An impairment in reactive
hyperemia has been observed in patients with multiple disorders, including diabetes mellitus [31,
60, 113, 115, 116, 148], essential hypertension [149, 150], coronary artery disease [122],
hypercholesterolemia [71], peripheral arterial occlusive disease [151], end-stage renal disease
[99], and sepsis [152]. A typical LDF result from studies comparing healthy subjects and patients
with endothelial dysfunction is shown in Figure 3.6. Spectral analysis of the cutaneous perfusion
signal is also useful for the evaluation of characteristic oscillation frequencies (i.e. flowmotion)
corresponding to influences from the heart beat, respiration, the intrinsic myogenic activity of the
vascular smooth muscle, the neurogenic activity of the vessel wall, and the vascular endothelium
[153]. These have been demonstrated to be dependent on arteriolar diameter oscillations, i.e.
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vasomotion, which is a critical factor in the optimal distribution of blood flow in the skin
microcirculation [154]. Due to the finely controlled nature of skin blood flow, researchers have
begun using LDF to investigate skin flowmotion in response to vasoactive drugs and in certain
vascular diseases, including diabetes, hypertension, and peripheral arterial occlusive disease [24].
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Figure 3.6 Representative LDF measurement during test of Post-Occlusive Reactive Hyperemia (PORH):
Comparison of a healthy subject and a subject with endothelial dysfunction.
A major limitation of the reproducibility and cross-study comparisons involving LDF is its
significant site-specificity that can lead to considerable spatial and temporal variations. The
spatial heterogeneity of skin lowers the reproducibility of the desired perfusion index since skin
blood flow signal varies markedly depending on probe position. Considering the heterogeneity of
the skin vasculature, studies comparing multiple LDF measurements must make measurements at
identical sites under identical environmental conditions. Moreover, the device only examines a
superficial layer of dermis in a small, yet undefined volume of tissue and may require several
measurement sites for an accurate representation of tissue perfusion. Finally, no current laser
Doppler instrument can present absolute perfusion values (e.g., ml/min per 100 g tissue) and
measurements are expressed as perfusion units, which are arbitrary and related to a pre-defined
electrical signal, which is often set by individual device manufacturers. Thus, LDF
measurements are only valid on a relative scale with respect to the specific patient and tissue of
interest.
A recent advance in the field is that of laser Doppler imaging (LDI), a non-contact device that
generates two-dimensional maps of perfusion based on the same principles of LDF [155]. With
systematic scanning of a defined region, this technique allows an estimate of the temporal and
spatial heterogeneity of skin blood flow. However, the resulting signal is still expressed in
relative units and the quality of validation is limited to a small number of studies.
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3.4.2 Orthogonal Polarization Spectral (OPS) Imaging
Orthogonal polarization spectral (OPS) imaging is a noninvasive technique that uses reflected
light to produce real-time images of the microcirculation on the surface of solid organs and
through mucous membranes [156]. Of the possible tissue beds, the sublingual mucosa has been
most extensively studied [157, 158]. Visualizing the microcirculation allows investigators to
detect microvascular pathologies and quantify perfusion in the microcirculation. In contrast to
studies using laser Doppler or plethysmography to investigate global microvascular blood flow,
OPS imaging allows assessment of the heterogeneity of the local microcirculation.
In OPS imaging, polarized light in one plane is directed towards the tissue of interest by a set of
lenses. As the light reaches the tissue, the depolarized light is reflected back through the lenses to
a second polarizer, or analyzer, oriented orthogonal to the first polarizer. If a wavelength within
the hemoglobin absorption spectrum (e.g. 548 nm) is chosen, small blood vessels containing red
and white blood cells can be clearly seen. The vessel walls themselves are not visualized directly
and their imaging depends, therefore, on the presence of red blood cells. By definition, only
vessels containing red blood cells will be visualized, providing a measure of perfusion in the
analyzed tissue. The technology has been incorporated into a small hand-held video-microscope
which can be used in both research and clinical settings [156]. OPS can assess tissue perfusion
using the functional capillary density (FCD), defined as the length of red blood cell (RBC)-
perfused capillaries per observation area (measured as cm/cm2). The speed of blood flow can be
estimated by software used to analyze dynamic capillaroscopy, although the current technical
limit for blood flow velocity determination is approximately 20 mm/s [159].
Functional capillary density is a direct measure of the state of nutritive perfusion to the tissue and
is an indirect measure of oxygen delivery. The prior use of sublingual tissues with OPS provides
information about the dynamics of microcirculatory blood flow, and has been studied as a
monitor of perfusion during the clinical treatment of circulatory shock [160]. However,
alterations in the sublingual microcirculation may not be representative of blood flow in other
microvascular beds. Noting the need for the OPS technique in dermatologic investigations, Lupi
et al. [161] reviewed the prospects of OPS imaging in assessment of microcirculation in the skin,
stating that the technique is promising in the study of vasculitis, chronic venous insufficiency,
and skin tumors. OPS measurements have also been validated against intravital fluorescence
microscopy in experimental models of skin wound healing [162].
However, there are limitations of the technique that restrict its usefulness in studies involving the
skin. In particular, OPS imaging is influenced by the amount of melanin at the dermal-epidermal
junction, making visualization difficult in individuals with a large amount of melanin in their
skin. The variability of skin thickness also complicates measurement as image resolution is good
for tissue depths of approximately 300 gm [163], although penetration of up to 3 mm has been
reported [161]. Moreover, to be a useful monitor of perfusion, the obtained images must be
interpreted uniformly and quantification of microcirculatory flow must be reproducible. Due to
the inherent heterogeneity of the microcirculation and technical requirements of OPS imaging, a
temporal assessment of tissue perfusion is difficult to interpret based on momentary images of
individually perfused vessels. Furthermore, analysis of microcirculatory parameters are semi-
quantitative and can only be performed 'off-line'.
3.4.3 Peripheral Arterial Tonometry (PAT)
The peripheral arterial tonometry (PAT) technique is very similar to arterial applanation
tonometry used to measure the radial artery pressure waveform [164], although with PAT, the
goal is to use the arterial waveform to derive the pulse wave amplitude (PWA). The technology
involves a finger plethysmographic device that allows the isolated detection of pulsatile arterial
volume changes. A proprietary PAT device (Figure 3.7), made by Itamar Medical Ltd., Caesarea,
Israel, consists of a pneumatic finger probe which covers the distal phalanx of the finger and
allows the application of a constant and evenly distributed near-diastolic counterpressure within
the entire probe. This increases sensitivity by unloading arterial wall tension and prevents venous
blood pooling and blood stasis, which could induce venoarteriolar reflex vasoconstriction [165].
Pulsatile volume changes of the fingertip are sensed by a pressure transducer and transferred to a
personal computer where the signal is filtered, amplified, displayed, and stored. The RH-PAT
(reactive hyperemia peripheral arterial tonometry) technique has been developed specifically for
evaluation of endothelial function and permits the noninvasive assessment of peripheral vascular
reactivity by measuring digital pulse volume at rest and during reactive hyperemia.
Figure 3.7 RH-PAT finger plethysmographic device developed by Itamar Medical
Used originally to measure peripheral vasoconstriction during REM sleep [166], this technology
has since been found to demonstrate impaired digital hyperemic response corresponding to
coronary artery disease. Based on the technique of measuring endothelial function through NO-
mediated vasodilatation, a study carried out by Bonetti et al. [167] examined PWA changes
following brachial artery occlusion with a blood pressure cuff. The extent of reactive hyperemia
was calculated as an RH-PAT index, defined as the ratio of the average amplitude of the PWA
over a 1-min time interval beginning after exactly 60 seconds of reactive hyperemia divided by
the average PWA for the 210 second-period before cuff inflation (baseline). The RH-PAT device
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was tested on 94 consecutive patients who were referred for coronary angiography. The average
RH-PAT index was lowered in individuals with known coronary artery disease and demonstrated
a correlation with coronary artery response to acetylcholine (see Figure 3.8).
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Figure 3.8 Representative RH-PAT signal recorded in subjects with normal and abnormal reactive
hyperemic responses. Normal response is characterized by a distinct increase in the signal amplitude after cuff
release compared with baseline. [167]
In another study conducted by Kuvin et al. [165], it was found that a lower RH-PAT index (here,
called PAT hyperemia ratio), was related to factors known to affect endothelial function, such as
hypertension, hyperlipidemia, and tobacco use. The investigators also demonstrated endothelial
behavior similar to that of flow-mediated vasodilatation of the brachial artery such that the PAT
hyperemia ratio was reduced in subjects with impaired endothelial function represented by low
FMD and was higher in subjects with greater brachial artery FMD responses consistent with
more preserved endothelial function. These studies confirm that a reduction in digital PWA
reactivity coexists with evidence of endothelial dysfunction in coronary and brachial arteries of
individuals with atherosclerosis or its risk factors.
Blood flow in the fingertip can vary by a great amount due to the overwhelming presence of
arteriovenous anastomoses, which are primarily regulated by the sympathetic nervous system.
Prior investigations have shown that nitric oxide plays a minimal role in controlling resting
digital blood flow [168, 169]. This poses questions regarding the validity of evaluating digital
endothelial dysfunction since decreased nitric oxide bioavailability is a defining characteristic of
endothelial dysfunction and cardiovascular disease. Nohria et al. [170] have demonstrated that
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nitric oxide is the principle mediator in modulating digital vascular function in response to a
reactive hyperemia flow stimulus. In their study, there was a significant reduction in digital PWA
response during reactive hyperemia when nitric oxide production was inhibited by the nitric
oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME). In agreement with the
prior investigations, inhibition of nitric oxide synthase did not alter baseline digital PWA. The
results from Nohria et al. establish a central role for nitric oxide in digital reactive hyperemia. It
is reasonable to conclude that measurement in the fingertip provides a simple and noninvasive
method of assessing nitric oxide bioavailability and endothelial function, despite its relative
absence during resting blood flow.
The FDA-cleared PAT technology can be applied to measure obstructive sleep apnea as well as
endothelial dysfunction. The RH-PAT method for measuring endothelial dysfunction is
integrated into the Endo-PAT2000 system and is marketed as a noninvasive tool with the
potential to identify patients during the early stages of cardiovascular disease with a simple test
based on digital reactive hyperemia [171]. Further research must be done to explore the
possibility of applying such a screening index in the general population and to investigate
whether the RH-PAT index augments conventional risk scores.
3.5 Current Methods of Noninvasive Assessment: Thermal Methods
The qualitative and indirect assessment of temperature and coloration in the skin is intrinsically
linked to tissue perfusion within the microcirculation. For example, a person with a flushed
appearance experiences warmth and a reddish color appears in the face and skin. A physician
will often note the healthy state of a patient's skin as being "warm and well perfused" while a
patient experiencing shock from low blood volume often has skin that is cold, clammy, and pale.
Many different methods have been developed to investigate skin perfusion based on thermal
principles. The following discussion will focus on those which have applied temperature-based
approaches to evaluate perfusion or to assess clinical signs of cardiovascular disease or
circulatory distress. The history of thermal techniques for the measurement of local tissue
perfusion is reviewed extensively by many researchers, including Bowman et al. [172], Eberhart
et al. [173], Bowman [174], and Chato [175]. This section will address the thermal methods that
have been applied in a noninvasive way to assess microvascular perfusion of the skin.
3.5.1 Skin Surface Temperature Gradients
The digital skin surface temperature and core-digit temperature gradients have been proposed for
the monitoring of peripheral perfusion in a variety of clinical situations. Since toe temperature
was initially studied as an indicator of the severity of circulatory shock [ 176], body temperature
gradients have been used in the monitoring of postoperative care to assess changes in
intravascular volume [177], weaning of cardiopulmonary bypass to assess the adequacy of
rewarming [178], and active core cooling to detect thermoregulatory vasoconstriction [179]. The
principle of core-to-peripheral temperature gradients is based on the transfer of heat from the
body core to the skin, which is controlled by the degree of peripheral vasoconstriction. During
vasoconstriction the temperature of the skin falls and the heat conduction from the core
decreases. As a result, the core temperature rises and the core-to-peripheral temperature gradient
increases. A gradient of 3-7"C normally occurs in patients with stable hemodynamics [180].
The forearm-to-fingertip skin temperature gradient has also been used as an index of peripheral
perfusion. Studies have compared the skin surface temperature gradients to total finger blood
flow measured with venous-occlusion volume plethysmography and laser Doppler flowmetry,
with favorable results [181, 182]. The preferred use of peripheral skin temperature gradients over
a core-to-peripheral temperature gradient is based on its usefulness in non-steady state
conditions, such as in patients undergoing surgery. Since the forearm skin site is exposed to the
same ambient temperature as the fingertip, both are similarly affected by environmental
temperature fluctuations, producing little influence in the gradient. This parameter has been
proposed as an inexpensive and easy-to-use measure of thermoregulatory peripheral
vasoconstriction, particularly in anesthetized patients undergoing surgery [183].
A number of studies have examined the correlation between core-to-peripheral temperature
gradients and global hemodynamic variables in hypovolemic, septic and cardiogenic shock,
although these have produced conflicting results [180]. A primary source of the discrepancy
between a measured body temperature gradient and global hemodynamic parameters in an
operating room could be related to an unstable environment, as skin temperature depends on
ambient temperature. Another reason may be that global hemodynamic parameters may not be
sensitive enough to reflect changes in peripheral blood flow in critically ill patients. Although
the forearm-to-fingertip skin temperature gradient offers a validated alternative approach, its use
in these conditions has not yet been defined. Nevertheless, it has proven to be a reliable method
of evaluating peripheral vascular responses compared to other standard measurements such as
finger volume plethysmography and laser Doppler flowmetry.
3.5.2 Thermal Clearance
The thermal clearance technique is based on the theory first described in 1933 by Gibbs [184] in
which the rate at which heat is carried away from a source is dependent on conduction through
the tissue and local blood perfusion. The first surface-mounted thermal clearance probe using
three thermocouples in series was proposed in 1956 by Hensel and Bender [185] and was
subsequently improved by the work of Kuiper and van de Staak [186]. Their probe consists of
two concentric copper discs separated by a small, known distance that is placed in contact with
the skin. The temperature difference between the central heated disc and the unheated, concentric
annulus is measured by thermocouples and related to rate of removal of heat from the center of
the probe by the blood flow in the skin at that location. When blood flow is high, the heat is
dissipated at a greater rate and the temperature difference is low. When blood flow is low, heat
dissipation is reduced and the temperature difference between the rings is increased. The
effective thermal conductivity that is determined contains a convection component related to the
skin blood flow.
Improvements and modifications to the method have been explored by many researchers with
varying degrees of success [187-192]. The method has been used by many investigators in
studies to assess its relationship to other measures ofperfusion, such as laser Doppler flowmetry
and volume plethysmography [193-195] and has been investigated for use in pathological states,
such as Raynaud's disease and bums [196, 197]. Nevertheless, it is ultimately limited as a
qualitative measure of skin blood flow [195, 198]. Furthermore, its value as a measure of nutrient
perfusion in the skin (originally advocated by Holti and Mitchell [191]) has since been proven to
be unrealistic in certain locations (e.g. fingers) due to its depth discrimination, which includes
flow through arteriovenous anastomoses [199]. This is comparable to the tissue penetration of
LDF.
Efforts to gain quantitative measurements of skin blood flow have been investigated. Jaszczak
and Serjsen [200] and Midttun et al. [201] employed a "heat-washout" method for quantifying
blood flow. With this technique, heat is modeled as a diffusible indicator using the principle of
Kety's local indicator washout method [202]. After measuring the baseline skin temperature, the
temperature of an insulated heater is raised between 2-10"C above baseline values. Once steady-
state temperature is reached after 3-5 minutes, the heat is turned off and the temperature decay to
baseline is monitored. Flow is calculated afterwards using Kety's principles. Midttun et al.
compared the calculated perfusion with xenon clearance and found a high degree of correlation
between the two, although they did experience conductive heat losses to the air via the probe and
the tissue.
3.5.2.A Surface Thermistors
Thermistors have also been used to monitor skin temperature by measuring their temperature-
dependent changes in electrical resistance. For negative temperature coefficient (NTC)
thermistors, electrical resistance decreases as skin temperature increases. Furthermore,
thermistors are capable of generating heat when a current is applied. These characteristics have
made it useful in assessing thermal clearance in the skin in a variety of ways. However, none
have been successful in accurately tracking and quantifying quickly fluctuating perfusion in
absolute units and in real time. The developments presented in this particular area lay the
groundwork for the current noninvasive probe design of focus.
In 1979, Patera et al. [203] designed a technique of measuring perfusion using a flake thermistor
placed on the surface of a tissue. They applied a sinusoidal heat flux and measured the phase
shift between the applied signal and the corresponding tissue surface temperature response. For a
given applied frequency, this phase shift was a function of perfusion and the intrinsic
conductivity of the tissue. Additionally, the method was independent of the temperature of the
probe or tissue. However, the phase shift was very small for normal levels of perfusion, making
measurement difficult. Furthermore, the accuracy of the calculated perfusion decreases with
increasing driver frequency such that dynamic perfusion fluctuations above approximately 0.1
Hz are lost. As a result, the method is inappropriate for studies of vasomotion. Since Patera et al.
first proposed a sinusoidal heating technique, Anderson and Burnside [204] have applied the
concept of sinusoidal heating of the skin using ultrasound to calculate perfusion from the phase-
shifted temperature response. Liu et al. [205] have also improved upon the original heating
algorithms to establish a similar method with a more strict theoretical foundation.
Castellana et al. [206] developed a surface thermal probe consisting of a platinum flake
thermistor with an insulating foam support. The thermistor rests on the surface of a tissue and is
heated to a fixed temperature while the power to maintain that temperature elevation is
measured. The steady-state response of the probe to flow changes is then related to perfusion by
a theoretical analysis of the bio-heat transfer equation, which the investigators solved using a
Fourier series method. In 1984, Walsh [207] designed a noninvasive probe consisting of two
flake thermistors, achieving good sensitivity to changes in perfusion. He also created an
analytical one-dimensional model of the noninvasive probe which indicated that the dimensions
of the surface probe were more appropriate for a spherical model, rather than a model of the
probe as an infinite slab. Patel et al. [208] investigated the use of a spherical surface thermistor
embedded in an insulator and applied to an isolated, perfused rat liver apparatus. The
thermistor's response to perfusion was modeled with a simplified bio-heat equation in which
effective thermal conductivity is a linear function of perfusion. Although they demonstrated
probe sensitivity to changes in perfusion, the investigators experienced significant errors caused
by baseline temperature drift and poor probe-tissue contact.
Noninvasive thermal probes have had limited success with respect to perfusion measurement.
There is often difficulty in measuring the actual heat flux going into the tissue due to losses to
the ambient air. Many researchers have also encountered problems with the probe-tissue
interface, as there is both an issue of thermal contact resistance and of capillary collapse with
applied pressure.
3.5.3 Convective Perfusion Bioprobe
Another effort to measure skin perfusion noninvasively has been pursued by researchers at
Virginia Tech. Based on the original work of Michener et al. [209] and later, Fouquet et al.
[210], the "bioprobe" consists of a heat flux sensor and surface thermocouple that is placed in
contact with surface tissue, while the opposite side is cooled, rather than heated. Cooling of the
tissue generates heat flux through the probe. Cooling was original accomplished by water
channels, but O'Reilly et al. [211] improved upon the probe design by using pressurized air jets.
An analytical thermal model was developed to relate the measured heat flux and temperature of
tissue to obtain a value for perfusion as well as probe contact resistance through parameter
estimation techniques, where the measured heat flux is compared to an estimate predicted by the
model in order to solve for the perfusion term in the bio-heat equation.
Further probe and parameter estimation development has been described by the work of
Robinson [212], Scott et al. [213], Cardinali [214], Mudalier [215] and others. A thorough
history of the Virginia Tech Bioprobe is provided in Mudalier's 2007 PhD dissertation [215].
While the method has been shown to be sensitive to changes in blood perfusion in a canine skin
flap model, isolated rat liver system, exposed rat kidney system, and perfused phantom tissue
system, the model has not been independently validated for measurement of absolute blood flow.
Furthermore, variations in skin temperature, motion artifacts and fluctuating air temperature
disturb the measurement and confound the analytical perfusion extraction. It is also greatly
limited by the post-measurement processing necessary to estimate perfusion, resulting in a
clinically unacceptable situation.
3.5.4 Digital Thermal Monitoring (DTM)
In 2003 and 2004, researchers at the University of Texas explored a temperature-based technique
for measuring endothelial dysfunction [216, 217]. Their initial analysis of the method is based on
temperature changes in the skin of the distal palmar pad of the finger and various locations along
the forearm following vascular occlusion and release with an arm blood pressure cuff. Using
thermistors attached to the finger and forearm with foam tape, the investigators determined the
linear rate of temperature fall during a 5 minute pressure cuff occlusion and rate of temperature
rise following release. The percentage increase in the rate of rise compared to the rate of fall was
also considered [216]. From their studies, it was established that the distal finger temperature
was most responsive to a proximal blood flow occlusion. They also determined that the rate of
rise was significantly higher than the rate of fall in temperature [217]. A test of reproducibility
in one subject demonstrated a significant variability in the calculated ratio and the percentage
increase [216]. The studies were performed on subjects with little health history available and no
conclusions were drawn regarding its reliability in detecting endothelial dysfunction.
A device-based method of measuring endothelial dysfunction using finger temperature
monitoring has been developed by researchers at the University of Texas Houston Health
Science Center and the Texas Heart Institute and is marketed by a Houston-based company,
Endothelix, which was formed in December of 2003. The VENDYS ® device is a proprietary
technology which monitors temperature changes at the fingertip as a marker of endothelial
dysfunction, a method called Digital Thermal Monitoring (DTM). The test is conducted by
placing resistance temperature detector (RTD) probes on the palmar skin of the distal index
fingers of both arms. After a period of temperature stabilization, a pressure cuff is then inflated
around one arm to 50 mmHg above systolic blood pressure for two to five minutes. Fingertip
temperature usually drops one to two degrees during this period. When the cuff is deflated, the
reactive hyperemia is detected as a rise in fingertip temperature. The probes continuously
monitor the temperature changes and feed data to software for analysis. It is proposed that the
temperature overshoot and area "under the curve" during occlusion and release reflects the state
of normal or abnormal vascular reactivity (Figure 3.9). Temperature that struggles to reach
baseline indicates an impaired endothelium, while patients with normal endothelial function
overshoot the baseline temperature before settling.
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Figure 3.9 Parameters of Digital Thermal Monitoring (DTM) test of endothelial dysfunction [218].
Endothelix gained FDA approval of the VENDYS ® technology in 2007 and it is now available in
a cart model and portable briefcase model (Figure 3.10). Over the past few years, several clinical
studies have been performed by investigators from the Harbor-UCLA Medical Center and Lenox
Hill Hospital of New York. Due to the relatively recent development of the DTM technology,
there is little published clinical information available in peer-reviewed journals. However,
abstracts and posters from scientific meetings available on the Endothelix website [218] indicate
that the VENDYS® index of endothelial dysfunction obtained by the DTM technique is
correlated with traditional cardiovascular risk factor scores (Framingham Risk Score) [219, 220],
coronary calcium score [220], as well as presence of metabolic syndrome and diabetes [221 ].
Measured parameters have included temperature rebound (TR), slope of recovery, percent of
temperature rebound (compared to initial pre-occlusion temperature), and area under the
temperature curve (AUC).
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Figure 3.10 VENDYS ® technology. The DTM system is available in a cart model (A) and a briefcase model (B).
The DTM temperature probe (C) can be used to monitor temperature in 15 separate locations although only 2 are
required for the test.
A study of reproducibility was reported in an Endothelix white paper for short-term (1 day) and
long-term (3 months) variability of DTM measurements [222]. The results for AUC and TR
presented coefficients of variation between 8.9% and 11.5% for short-term measurements and
between 8.25% and 16.5% for long-term measurements. The investigators claim this is within
acceptable limits of reproducibility. However, it is noted that these results were obtained in a
controlled research environment in which participants were measured after an overnight fast and
after each had rested 30 minutes in a supine position in a dimmed, temperature-controlled room.
These conditions are not always possible for routine clinical use and it remains to be determined
how reproducible DTM is in a typical operating environment.
Compared to peripheral arterial tonometry (PAT) technology and other methods of noninvasive
assessment, the VENDYS® DTM technique of evaluating endothelial function is proposed as
being a more rapid and operator-independent form of endothelial testing and provides
simultaneous data output. With this technology, the founders of Endothelix hope to provide a
noninvasive, non-imaging, low-cost tool for detection of endothelial dysfunction in routine
clinical practice.
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3.6 Clinical Implications of Noninvasive Endothelial Function Assessment
Atherosclerosis is the leading cause of mortality in the Western hemisphere and is widely
recognized as a systemic vascular disorder with complications in the coronary arteries, carotid
arteries, and peripheral circulation. Substantial resources have been devoted to the investigation
and treatment for such complications, but the ultimate goal lies in being able to prevent the
development of the basic disease or at least to identify those patients who are at risk for an acute
event, such as a heart attack or stroke, and to intervene before damage occurs.
Endothelial dysfunction is increasingly recognized as a key early step in the development of
atherosclerosis and is also involved in plaque progression and the occurrence of atherosclerotic
complications, such as myocardial infarction, angina, sudden death, and heart failure [223].
Atherosclerosis affects essentially all arterial beds including the thoracic and abdominal aorta,
coronary arteries, carotid arteries, and the peripheral, renal and mesenteric arteries. Endothelial
dysfunction is defined by a loss of self-regulating mechanisms which normally prevent
coagulation and inflammation, and promote proper regulation of vascular tone. Thus, the
assessment and treatment during the preclinical stages of atherosclerosis requires quantitative
measurements of both functional (i.e. flow-mediated vasodilatation) and structural abnormalities
(e.g. atherosclerotic plaque).
3.6.1 Epidemiology
Cardiovascular diseases are the single largest killer of both men and women in the United States.
According to statistics compiled by the American Heart Association, CVD was determined as the
underlying cause of death in 36.3% of all deaths in 2004 [224]. CVD claims about as many lives
as the next four leading causes of death (cancer, chronic lower respiratory disease, accidents and
diabetes mellitus) combined. An estimated one in three adults have at least one form of CVD.
Many unexpected cardiac deaths occur without prior recognition of cardiac disease.
The category of cardiovascular disease includes:
* High blood pressure
* Coronary heart disease (CHD)
* Heart failure (HF)
* Cerebrovascular disease (stroke)
* Peripheral arterial disease (PAD)
* Atherosclerosis and other diseases of arteries, arterioles, and capillaries
Several important factors will serve to accelerate the rate of cardiovascular disease and its
complications in the coming years:
* Aging of the population
* Increase in the prevalence of obesity and type II diabetes with their related complications
of hypertension, hyperlipidemia, and atherosclerotic vascular disease.
An alarming increase in unattended risk factors in the younger population (obesity, lack
of physical inactivity, poor dietary habits, early onset type II diabetes, teenage smoking)
The estimated cost of cardiovascular diseases (direct and indirect) in the United States for 2008
is estimated at $448.5 billion. This figure includes health expenditures (direct costs) as well as
lost productivity resulting from morbidity and mortality (indirect costs). For comparison, in 2007
the estimated cost of all cancers combined was $219 billion [224].
3.6.2 Risk Assessment
Despite several available risk assessment approaches, a substantial gap remains in the detection
of asymptomatic individuals who ultimately develop cardiovascular complications. Ideally, a
screening test to aid in further risk stratification would [225]:
a) identify high- and low-risk groups more accurately (e.g., low proportion of false negative
and false positives).
b) enhance the identification of high-risk individuals.
c) result in a favorable impact on disease outcomes.
d) be relatively free of risk.
e) be cost-effective when compared to the current screening modalities.
f) educate the public concerning atherosclerosis and vascular disease risk.
Vascular disease prevention is most cost-effective in high-risk patients, but the strategy of
identifying patients with elevated levels of risk factors is problematic because traditional risk
factors (e.g. cholesterol, blood pressure, smoking, etc.) predict only half of vascular events. The
goal of cardiovascular disease (CVD) screening is to accurately determine risk early in the
natural history of disease, before an individual is considered high-risk. An objective measure of
atherosclerotic burden would also aid clinical and research-oriented applications beyond risk
stratification, including evaluation of patient response to interventions and identification of novel
genetic, cellular and molecular determinants of risk. This has motivated numerous investigators
to develop new biomarkers and diagnostic modalities that could help narrow the gap left by
traditional risk assessment.
3.6.2 Primary Prevention
Early detection of endothelial dysfunction and subsequent lifestyle modifications could greatly
increase survival from cardiovascular complications and reduce CAD risk. Numerous factors
contribute to reducing cardiovascular risk, including exercise, dietary modifications, blood
pressure reduction, and smoking cessation. Also shown to be associated with improved
endothelial function are interventions such as antioxidant therapy, lipid-lowering therapy, ACE
inhibitors, hormone replacement therapy, drug therapy to increase insulin sensitivity in diabetics,
etc (Table 3.1).
In addition to early detection, the effectiveness of therapeutic intervention or lifestyle changes
can be tracked over time, providing quantitative measures in achieving certain goals of
treatment. For example, measuring carotid plaque area by ultrasound has been presented as a
way to evaluate and track severity of cardiovascular burden [226]. Measuring plaque as a
continuous variable appears to be more powerful than simply detecting the presence or absence
of plaque at extracoronary sites or counting the number of sites involved. Regression of plaque is
also used as the therapeutic goal so that follow-up measurements of plaque can determine
whether therapy is successful. In practice, showing patients the pictures and measurements of
their plaque progression often seems to help motivate them to implement lifestyle changes such
as smoking cessation and dietary change. Moreover, plaque regression validates and encourages
persistence with successful lifestyle changes [226]. Since it is currently common for many
people to track their blood pressure as an index of current health, it is not hard to imagine other
noninvasive indices, such as endothelial function, entering into mainstream comprehension with
the development of cheap, diagnostic instruments. Table 3.2 summarizes the potential clinical
value of endothelial function testing.
Table 3.2 Endothelial function assessment in standard clinical practice. Table adapted from [103].
Clinical significance of endothelial function assessment
Endothelial function integrates the influences of numerous risk factors (hereditary,
environmental, lifestyle-related)
Endothelial dysfunction precedes morphological changes in vascular systemic and clinical
manifestations of cardiovascular disease - indicating a need for early and effective prevention
Endothelial dysfunction is reversible by healthy lifestyle change or medical therapy
Noninvasive assessment of endothelial dysfunction provides independent prognostic information
in various cardiovascular conditions
Chapter 4. Heat Transfer Mechanisms and Tissue Perfusion
The theoretical advantage of thermal perfusion measurement lies in the ability to quantitatively
assess absolute blood flow values with a mathematical model of the heat transfer interactions in
perfused tissue. To accomplish this, an effective thermal conductivity is determined
experimentally which describes the ability of the tissue to conduct heat by both conduction and
convection (blood flow). This integrated measure of tissue conductivity simplifies the complex
vascular geometries inherent in living tissue. Thermal methods have long been investigated for
use as a clinical measurement of tissue perfusion. The attraction to such a method lies in its
potential for meeting the high clinical standards of simplicity, patient safety, applicability across
all vascular beds, and measurement speed, accuracy, and reproducibility. Few other methods are
able to meet all of these clinical requirements.
4.1 Heat Transfer Principles
The relevant modes of heat transfer that occur in living tissue include tissue conduction,
metabolic heat generation, storage of thermal energy, convection by microvascular perfusion,
and energy absorbed from external sources [227]. Individual contributions from each of these
mechanisms leads to a dynamic thermal system - one which is highly complex, heterogeneous in
its structure and composition, and capable of maintaining equilibrium on a local and a global
scale. Moreover, the skin surface provides an interface between the heat transfer mechanisms of
the body and those of the environment. While heat within the body is transferred mainly through
conduction and convection, heat transfer in ambient surroundings occurs by conduction,
convection, radiation, and evaporation.
Conductive heat flow is governed by Fourier's Law, which relates the time rate of heat transfer,
q, to the temperature gradient at the point of interest,VT with the equation
q = -kVT
Here, q is the heat flux vector (W/m2) normal to the direction of heat flow, and the negative sign
ensures heat flow occurs in the direction of decreasing temperature. The proportionality constant,
k, is defined as the intrinsic thermal conductivity, and it is this material property that determines
the ability of a material to transfer thermal energy in the steady state. Thermal conductivity may
be defined as heat flow density per unit of time for a certain temperature difference and, in
biological materials, is often measured in mW/cm-*C.
In a transient state, the conduction heat transfer is described by another Fourier equation:
1 0TV2T =1
oc dt
which is the partial differential equation that describes the time-dependent temperature
distribution within a material. The thermal diffusivity, oc, determines the rate at which heat
diffuses through the body and is dependent on the material's thermal conductivity, density, p,
and specific heat, c, according to the relationship,
k
oc=-
pc
Thus, thermal diffusivity is the material property that measures the ability of a thermally
perturbed system to return to steady-state conditions [172]. In biologically active materials, there
are complex interactions between tissue conduction, perfusion, and metabolism that contribute to
heat transfer processes. To gain an analytical understanding of these processes and derive
relevant tissue thermal properties, a mathematical idealization of the physiological circumstances
is commonly employed.
The effective thermal conductivity of perfused tissue depends on two modes of heat transfer:
conduction and convection. Heat conduction depends on the nature of the tissue and generally
remains constant, while heat transfer due to convection depends primarily on blood flow. The
three primary conductive components of living tissue are proteins, lipids, and water [228]. The
thermal conductivity of both proteins and lipids is approximately 1.8 mW/ cm. °C. Water's
conductivity is much higher at about 6.23 mW/cm. °C. Thus, in the absence of blood flow, the
thermal conductivity of a tissue depends largely on its water content.
4.2 Thermal Model of Bio-Heat Transfer
The heat transfer interaction between blood in the vascular network and tissue has been a closely
studied interaction, as it is critical to many natural physiological processes in the body. However,
to model the heat transfer processes is both an intricate and exceedingly difficult undertaking.
Tissues in the body are anisotropic and inhomogeneous, while the complex and irregular
organization of the vascular system is further complicated by blood flow that varies greatly over
time in diverse organs and tissue throughout the body[172]. The most common analytical
approach taken to study bio-heat transfer mechanisms is to model the physical or physiological
situation in terms of a mathematical idealization that accounts for individual heat transfer effects
in the biological system. In terms of perfusion, this often involves accounting for the thermal
interaction between microvascular blood flow and the perfused tissue.
The experimental work of Pennes in 1948 [229] led to the development of a bio-heat equation
that described the effects of metabolism and blood perfusion on the energy balance within tissue.
It was assumed that the capillary bed was the major site of heat exchange between the tissue and
blood due its considerable surface area. Therefore, the volumetric rate of heat exchange between
blood and tissue, 4 b1 (in W/mL), is a function of the volumetric perfusion rate, w, measured in
grams of blood per mL of tissue per second.
4bl = OCbl(Ta - Tm)
Here, cbl is the specific heat of blood, Ta is the arterial temperature, and Tm is the tissue medium
temperature. It is also assumed that thermal equilibration occurs in the capillary bed such that
blood enters the capillaries at the temperature of arterial blood and enters the venous circulation
at the temperature of the surrounding tissue. No energy transfer occurs before or after the blood
enters the capillaries. Chen and Holmes [230] and Chato [231] have since demonstrated that
significant thermal equilibration between blood and perfused tissue occurs prior to reaching the
capillaries, between the terminal arterial branches and the precapillary arterioles. However, the
Pennes equation still appears valid if larger, "thermally significant" vessels are evaluated
separately [227].
Considering a control volume of tissue, we see that the cumulative rate of change of thermal
energy stored in the control volume depends on the sum of local heat transfer contributions
rate of ] [net rate of [ rate of
energy storageJ = energy gainj energy generation]
The change in internal thermal energy is directly related to the ability of the tissue medium to
store heat by raising its temperature[ rate of 1 'Tm
energy storage] at (T)m = mCM a
Summing the individual heat transfer contributions of transient heat conduction, convection due
to perfusion, and energy generated due to tissue metabolism, we have the familiar Pennes bio-
heat equation:
dTm
Pmc at = kmV 2Pm + (JCbl(Ta - Tm) +
There are notable simplifications in the Pennes model, which describes the temperature field in a
homogenous biological medium with isotropic thermal properties. The heat balance assumes that
local heat generation is a nondirectional property and that blood flow is nondirectional at the
capillary level. Additionally, all convective heat exchange occurs in the capillary system, an
assumption which is only valid for blood vessels of terminal arterial branches and smaller
vessels.
Alternative bio-heat transfer models have been proposed to account for over-simplification in the
model proposed by Pennes. All involve a more complex analytical approach and reduced
generality for perfusion measurement applications. Seeing as the current Thermal Diffusion
Probe follows from the Pennes model, these will not be addressed here. For further background,
an in-depth review of the literature on mathematical modeling of bio-heat transfer is presented by
Charney [232].
4.3 History of Thermal Tissue Perfusion Measurements
Thermal methods for measurement of tissue perfusion have been pursued by many investigators
for over 70 years. The most common approach involves the principle of thermal clearance in
which blood flow is derived from the rate of removal of thermal energy from a heated area of
underlying tissue. Gibbs [184] was among the first to propose an approximate method for the
estimation of perfusion based on heat clearance with a "thermoelectric blood flow recorder." A
brief history of the thermal perfusion measurement research performed before 1970 by Von
Rein; Hensel, Betz, and Bender; Grayson; and Perl and Hirsch is given by Walsh [207]. Since
these initial contributions to the field, significant advances have been made in both
instrumentation and developing analytical solutions from more complete equations that describe
the tissue energy balance.
The conceptual foundation for most modem techniques of thermal property measurement
consists of a system where a heat source that also acts as a temperature sensor is introduced into
the specimen and the thermal conductivity is determined based on the transient temperature
measurements. Variations on this technique are the heated thermocouple [233-236], or the
thermistor probe [237-239]. The embedded thermistor probe technique first used by Chato [238]
modeled the probe as a lumped thermal mass and solved the heat diffusion equation in the
surrounding medium. The inaccuracies in this technique were later addressed by the
improvements to the thermal model by Balasubramaniam and Bowman [237], in which a pair of
coupled heat diffusion equations were developed for the interior of the thermistor and the
surrounding tissue medium, thus accounting for the thermal gradients within the probe by
modeling it as a distributed thermal mass. Using the Pennes bio-heat equation, they were then
able to model the effect of perfusion on tissue heat transfer [240]. By determining the power
required to maintain a controlled probe temperature increment above the tissue temperature, it
was possible to calculate perfusion from the solution to the steady-state perfusion model for the
probe and surrounding tissue.
A major contribution towards measurement of absolute blood flow was made by Valvano et al.
[239]. Using a spherical thermistor embedded at the tip of a flexible catheter, Valvano
formulated the closed-form, transient solution for a heated probe in perfused tissue, which led to
an algorithm for extracting perfusion from both the steady-state and transient models. Using this
probe alongside a radioactive microsphere technique in an ex vivo rat liver model, Valvano
showed that absolute perfusion could be measured with an accuracy of about 10% over the
perfusion range of 60 to 200 ml/min- 100g.
After substantial development and testing of the thermistor probe technique, Bowman and
colleagues created a commercial device for minimally invasive measurements of tissue thermal
properties and perfusion. The Thermal Diffusion Probe has been progressively refined over the
past three decades and has been validated against XeCT, Doppler flowmetry, H2 clearance, and
the radioactive microsphere technique [8, 241-243]. It has also been applied clinically in brain
surgery [8], reconstructive surgery [5], transplantation [7, 242], and other fields of medicine
desiring a continuous monitor of absolute blood flow in small volumes of tissue (30-100 piL).
After obtaining FDA regulatory approval in 2002, the Bowman Perfusion Monitor, developed by
Hemedex, Inc., has introduced the invasive TDP into clinical settings for routine perfusion
monitoring in real-time and absolute units.
Another transient technique for quantifying perfusion has been presented as an alternative to the
step temperature rise model. The Temperature Pulse Decay (TPD) method is a transient thermal
technique based on the introduction of a brief pulse of heat from a point source and the
subsequent perfusion-dependent temperature decay. First reported by Chen and Holmes [244],
this analytical method relates the measured temperature decay following a short, computer-
controlled heat pulse through a small thermistor bead to a theoretical temperature decay, which is
also based on the Pennes bio-heat equation [245]. The limitations of this technique restricted its
further development, as the small heating element was only able to interrogate a small volume of
tissue. The TPD method was further hampered by an unacceptably low sensitivity to perfusion
changes.
The ability to measure living tissue thermal properties has been both a challenge and an active
area of intense research. Living tissues depart from ideal engineering geometries, compositions
and boundary conditions. Furthermore, they must be studied in vivo to obtain accurate
measurements, as tissue thermal properties greatly depend on blood flow and water content.
Generally, the measurement of tissue thermal properties is performed via insertion of a thermal
probe into the biological specimen, often causing significant disturbance in the normal
physiological state of the tissue. In living organisms, this may cause obvious pain and
discomfort. Drawing on the knowledge gained from this extensive field of research, I will
present my investigation into developing a noninvasive thermal technique for measuring thermal
conductivity, diffusivity, and local blood perfusion in the skin in Chapters 5 and 6.
Chapter 5. Noninvasive Application of the TDP Probe
5.1 The Invasive Perfusion Probe: Design and Operation
5.1.1 Design
In contrast to the original thermal perfusion probe design by Balasubramaniam and Bowman
[237], the minimally invasive thermal diffusion probe (TDP) consists of two thermistors: a distal,
"heat" thermistor; and a proximal, "sense" thermistor (Figure 5.1). The addition of the sense
thermistor allows the quantification of perfusion using the thermal technique in tissues where the
temperature is varying over wide ranges. The two thermistors are contained at the end of a
flexible catheter that can be inserted into the perfused tissue of interest. The probe is connected
to an electronic monitor by an umbilical cord, where the data collection, storage, processing, and
display is controlled by an on-board microprocessor.
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Figure 5.1 The minimally invasive thermal diffusion probe (TDP) produced by Hemedex, Inc. [246]
To measure perfusion, the probe must measure a stable baseline (initial) tissue temperature, Ti.
The distal thermistor is then self-heated to a constant temperature slightly above the tissue
baseline temperature - usually an increment of about 2*C. The difference between the volume-
averaged probe temperature and Ti is defined as ATb (Figure 5.2). While the A Tb is established
almost instantaneously within the thermistor, the power, P, required to establish and maintain
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this temperature takes a very large initial value and then falls over time to a steady state value.
The proximal thermistor is located outside of the heated field and passively monitors tissue
baseline temperature, compensating for transient temperature fluctuations. The power dissipated
in the distal thermistor by resistive heating is related to the tissue's ability to carry thermal
energy by both thermal conduction within the tissue (q-) and by thermal convection due to local
perfusion blood flow (Obl). With this information, the probe-tissue heat transfer equations can be
solved continuously to provide real-time perfusion data.
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Figure 5.2 Temperature profile of the thermistor probe and tissue before and after heating. (A) Before
heating. (B) After heating, at two different levels of perfusion. km= tissue thermal conductivity; I= current;
R=thermistor probe resistance
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The thermal interaction between the perfusion sensor and tissue is described by a coupled set of
partial differential equations such that the thermal response of the sensor is described by the heat
diffusion equation and the response of the tissue is described by the bio-heat transfer equation. .
The solution for the temperature distribution in the heat thermistor and in the affected tissue is
necessary to extract perfusion and is derived from the following coupled, differential equations:
1 aTm, opblCbt
- V2Tm - Tm in the tissue
ocm at km
and
1 aTb 1P
= V2T, - in the probe
ocb at kb V
Here, Tm is the temperature elevation of tissue medium above the baseline; km is the tissue
intrinsic thermal conductivity; ocmis the tissue intrinsic thermal diffusivity; w is the local
perfusion rate; Pbl is the blood density; Cbl is the blood specific heat; Tb is the temperature
elevation in the sensor; OCb is the sensor thermal diffusivity; kb is the sensor thermal
conductivity; P is power dissipation and V is the sensor volume. The last term in the probe heat
diffusion equation represents the volumetric heat generation in the probe by resistive heating.
Metabolic heat generation is implicit in this model as a heat source which maintains the baseline
temperature.
The solution for the time-dependent probe-tissue temperature response in the presence of
perfusion was solved for by Valvano et al. [239] using a term-by-term Laplace transform,
converting the second-order system of partial differential equations into a second-order system of
ordinary differential equations. The heated thermistor is modeled as a uniformly heated sphere,
with perfect thermal contact between the probe and the tissue. It is assumed that power is
uniformly distributed throughout the thermistor bead to maintain constant mean volumetric
temperature. The boundary conditions require that temperature everywhere is bounded,
continuity of temperature and heat flux is maintained at the tissue-thermistor interface and that
temperature elevation approaches zero at infinity.
In the case of the spherical invasive sensor operated in constant mean temperature mode, the
model solution for probe power dissipation, P, as a function of the perfusion and intrinsic
properties is:
f (t)P 1 +ý7 ý
47rakmAT km 1 k[ m +1+Aa
5kb 1 + a 5kb
where
e a2 omt ( C tf(t) = e -a a2 /CM t
and
AWPblCbl
km
Here, a is the thermistor radius and AT is the sensor mean temperature rise above the baseline. In
the absence of a way to calculate tissue intrinsic conductivity in the presence of perfusion, the
intrinsic conductivity and the convective effects of perfusion can be determined in a no-flow
situation. However, this is not practical in clinical environments.
To account for any deviations from the model, the sensor thermal conductivity (kb) and the
sensor radius (a) are calibrated as constants for each individual sensor using measurements made
in media with known thermal properties. The monitor collects data on the power dissipated (P)
and the mean sensor temperature rise above baseline (AT). Therefore, the unknown variables are
the tissue intrinsic thermal conductivity (km), the tissue thermal diffusivity (ocm) and the tissue
perfusion (t). A significant advantage of the TDP method is the lack of a no-flow calibration
requirement to determine km. Instead, a series of algorithms are employed to extract the
conductive tissue properties from the initial rate of propagation of the thermal field as a function
of P and AT [239]. This component is separated from the total heat transfer to determine the
thermal convection component. With this method, perfusion, t, is not explicitly solved for, but
rather is solved in an iterative fashion.
5.1.2 Calibration
A thermistor is a temperature dependent resistor. Those used for thermal property measurements
have a negative temperature coefficient of resistance, indicating that their resistance will
decrease when their temperature is increased. Being resistive devices, a thermistor will also heat
when a current is passed through it. Both phenomena are exploited in the thermistor based
method for thermal property measurement. The thermistor is used both as a temperature sensor
and as a point heating source.
The calibration of a thermistor probe is a two-step process. The first step involves characterizing
the resistance-temperature relationship, while the second step defines the heat transfer properties
of the thermistor.
R-T Curve
The relationship between temperature and resistance is non-linear and is usually described by the
empirical Steinhart-Hart equation:
1
1 = C 2 1nR + C3 (ln R) 3
where T is the absolute temperature in Kelvin and R is the thermistor resistance in ohms. The
terms C1, C2, and C3 are empirically determined calibration coefficients. Thus, an experimental
set of data relating temperature and resistance in each thermistor is fit with a regression curve to
determine the calibration coefficients. The TDP thermistor probes are calibrated for temperature
following assembly using a platinum-resistance thermometer (from 25 C to 46 C). Using the
Steinhart-Hart relation, thermistors in the TDP are routinely calibrated to a resolution of 0.001 C.
Heat Transfer Properties: kb and a
The thermal conductivity and geometry of the thermistors must also be determined to accurately
model the heat transfer process. For a thermistor, the thermal conductivity ( kb) and the sensor
radius (a) are both determined by calibration in media of known thermal conductivities which
approximate the range of conductivities in biological tissue. Repeated, simulated perfusion
measurements are made within each media. This calibration is conducted in a constant
temperature bath and accounts for the sensor-to-sensor variability in resistance at a certain
temperature.
To allow for parallel production of the Thermal Diffusion Probes in appropriate quantities, the
calibration procedure is conducted in a semi-automatic, batch-wise process. Calibration values
are specific to individual probes. These are written to an EEPROM (Electronically Eraseable
Programmable Read-Only Memory) contained within the probe connector. The memory chip
also identifies each probe with a unique serial number that is associated with its calibration data.
5.2 Adapting Invasive Probe for Noninvasive Measurement
5.2.1 Sensor Placement
Previous informal studies have shown that the skin of the fingertip is an appropriate location for
measurement of perfusion and vasomotor activity with the thermal probe [247]. The palmar side
of the hand was used for most investigations and testing confirmed that the distal phalanx of the
finger (digit) exhibits a higher degree of signal detection (see Figure 5.3). This area of the finger
also has a high capillary density. It is also reasonable to choose the most distal part of the digit,
as it is very sensitive to changes in global blood flow distribution. For measurement of reactive
hyperemia, the digit is also an appropriate location since the sensor must be placed on the skin
surface distal to a blood pressure cuff challenge of the upper arm. Alternative methods for
noninvasive determination of endothelial dysfunction have often chosen to measure indices of
finger perfusion during reactive hyperemia. These include the previously discussed methods for
determining reactivity of finger blood flow by measuring peripheral arterial tone or digital
temperature.
Other practical considerations also influence the optimal placement of the thermal sensor.
Surfaces with fewer sweat glands are preferred since sweating can lead to artifacts caused by
evaporative cooling. Sweating can also progressively change the thermal conductivity during a
measurement period, which leads to perfusion artifacts. The sensor attachment site must not be
artificially warmed or cooled by other parts of the body, objects, or external influences. These
include changes due to temperature variations not resulting from vasoconstriction or
vasodilation, such as room temperature fluctuations, air currents, change in sensor location or
contact, etc. Due to the small thermal mass of the fingertip, special care must be taken to keep
environmental conditions constant and reduce movement or temperature variations.
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Figure 5.3 Noninvasive sensor measurement locations on palmar face of hand
5.2.2 Sensor-Tissue Surface Geometry
The invasive thermistor probes are designed and calibrated for use in a 4n geometry in which the
tissue medium completely surrounds the spherical probe. When applied to surface measurements
on skin tissue, the probe (or sensor) takes on a hemispherical, 27n contact surface geometry with
the tissue. Therefore, it is reasonable to suspect that the heat transfer properties of the probe for
surface measurements differ from those for invasive measurements. It also becomes important to
ensure that the same amount of surface area is exposed to tissue for heat transfer to maintain
consistent measurement environment conditions. For all surface measurements, a thick foam tape
was used to cover the thermistors and create an adiabatic environment (see Figure 5.4).
5.2.3 Contact Pressure
To achieve the appropriate thermal interface which ensures good thermal communication, a
suitable contact pressure must be applied to the sensor. However, significant changes in the
perfusion of skin occur when this pressure exceeds the sum of the tissue's biomechanical
compressive strength and the pressure for capillary collapse. Preliminary testing by G. Martin at
Thermal Technologies, where the current Bowman Perfusion Monitor technology was
developed, has addressed the issue of appropriate contact pressure in skin.
To define the requirements for the sensor-tissue interface, an invasive TDP was placed in contact
with the forearm skin of a volunteer. Relative perfusion was measured as a function of the
applied sensor pressure based on various weights placed over a defined sensor contact area.
Relative perfusion changes were also assessed with progressive displacement of a sensor into the
skin tissue, starting from the skin surface. The results showed that contact pressures greater than
about 0.5 mmHg result in significant decreases in relative perfusion. A sensor displacement
greater than 1.5 mm from the skin surface also results in a progressive drop in (relative)
perfusion. Martin noted that a peak in the relative perfusion was found with a sensor
displacement of approximately 0.6 mm, which may represent the sensor contact conditions most
suitable to optimize the balance between adequate thermal communication and uncompromised
perfusion.
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Figure 5.4 Schematic cross-section of exposed thermistors in TDP resting on surface of tissue. The
thermistors are insulated from the environment with a thick foam pad adherant to the skin.
5.2.4 Exposed Thermistor Beads
A modification of the invasive TDP construction was made to adapt the sensor for measurement
at the skin surface. The thermistor beads are typically contained within a thin flexible catheter to
enable simple insertion into soft tissue. However, this is unnecessary for a surface application
and adds unnecessary bulk to the sensor, which may affect contact pressure and depth of tissue
compression. By exposing the thermistor beads, preliminary measurements can be made to
determine the most appropriate method of applying the sensor to the skin (see Figure 5.5). There
is also the added advantage of tighter coupling between the sense thermistor and baseline skin
temperature, which is much more prone to variation at the skin surface than within soft tissue.
Note that the heated thermistor is slightly larger than the sense thermistor in the TDP. The exact
dimensions will be discussed in Chapter 6.
Heat Thermistor
Sense Thermistor
HEMEDEX
Figure 5.5 Bowman Perfusion Monitor and modified thermal diffusion probe (TDP) for noninvasive
application. The thermistors in the TDP are exposed to reveal the heat and sense thermistors. Perfusion and
temperature data are processed and stored in the Perfusion Monitor.
5.3 Measurement Protocol: Post-Ischemic Reactive Hyperemia (PORH)
5.3.1 Experimental Considerations
The measurement protocol for post-occlusive reactive hyperemia (PORH) is poorly standardized
for measurements ofbrachial artery diameter during flow-mediated dilatation and even more so
for the assessment of skin microvascular reactivity using laser Doppler flowmetry. Individual
variables, intra- and inter-individual variation, and environment-related variables can greatly
influence vascular measurements. Several conditions have been identified as being important
considerations for an experiment employing thermal perfusion measurement [27, 143, 248]. In a
clinical study, care should be taken to control for each of these factors and data should be kept
regarding any variations:
* Subject age, gender
* Time of the day when testing is performed
* Location of the occlusion cuff (upper vs. lower arm)
* Duration of the occlusion
* Length of withholding vasoactive medications
* Prior food intake (fasting)
* Consumption of nicotine, caffeine, and alcohol
* Phase of menstrual cycle, if appropriate
* Physical and mental activity
* Probe pressure on skin
* Skin temperature
* Ambient temperature, noise, humidity
* Subject position (sitting or supine)
* Anatomical site of measurement
* Length of stabilization period
These are provided to address the current knowledge concerning factors which may affect
perfusion response during a test of PORH. Due to the limitations in the current study setting and
population, the observed effects of various factors is noted when available, but no conclusions
can be drawn regarding their relative impact in a more general subject pool.
5.3.2 Protocol
The study protocol was approved by the Massachusetts Institute of Technology Committee on
the Use of Humans as Experimental Subjects (COUHES). Volunteer subjects signed a written
informed consent after receiving a detailed description of the study protocol, instrumentation, its
benefits and risks. The subjects then completed a questionnaire detailing their cardiovascular risk
factors, prior history of cardiovascular and other vascular diseases, and present medications.
Relevant health information was noted, including diagnosed coronary artery disease,
hypertension, hypercholesterolemia, peripheral arterial disease, or diabetes, as well as history of
myocardial infarction or stroke. As smoking has been identified as one of the factors influencing
basal skin perfusion and PORH responses [249], subjects were asked to report if they smoked
cigarettes.
Study conditions were standardized to minimize operator and subject variability. All
investigations were performed by an experienced research study operator. Subjects refrained
from eating, smoking, or drinking alcoholic or caffeinated beverages for the 4 hours prior to the
study. They were asked to refrain from ingesting any vasoactive medications for 24 hours before
the study, if possible.
All measurements were conducted in a quiet, temperature-controlled room at neutral room
temperature (22-24"C). Subjects were asked to lie in a comfortable supine position with their
experimental arm resting in a stable position at heart-level. Blood pressure was measured in the
contralateral arm after a period of acclimatization. A sphygmomanometer occlusion cuff was
placed around the upper arm of the experimental arm at a position 1-2 cm above the antecubital
crease, while the modified Thermal Diffusion Probe was placed on the skin of the distal phalanx
of the middle finger. In some cases, the thumb, index finger, or thumb pad (thenar eminence)
were used and noted (see Figure 5.3). Standard ultrasound gel was applied to the sensor-skin
interface to enhance thermal communication. The sensor was then covered with a piece of
flexible insulating foam tape (3M, St. Paul, MN) with a non-irritating adhesive that held the
sensor comfortably and securely next to the skin. A light cloth was wrapped around the hand and
forearm to insulate the hand from air currents or transient temperature changes. The hand was
then stabilized to prevent any subject discomfort or movement. Since the sensor is sensitive to
changes in position and orientation relative to the skin surface, any finger, hand or arm motions
can cause perfusion measurement artifacts and/or corruption of subsequent data.
A typical study sequence was conducted according to the procedure outlined in Figures 5.6 and
5.7. Since the TDP must reach temperature stability before perfusion measurement begins, there
is an initial temperature equilibration phase before perfusion calibration. The temperature
stability criterion for this study was a temperature change of not more than 0.001"C in 10
seconds. After the subsequent calibration period, a baseline perfusion measurement was recorded
for at least 5 minutes. Then, the cuff was then quickly inflated to a suprasystolic pressure (at
least 50 mmHg above systolic pressure) to occlude blood flow to the hand. The occlusion
pressure was maintained for 4 minutes before rapid cuff deflation. The measurement was
continued for approximately 5-15 minutes to allow for perfusion to return to baseline values.
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Figure 5.6 Outline of PORH test procedure
Figure 5.7 Perfusion and temperature are measured during an occlusive challenge to the arm
5.4 Measurement Issues
During data collection, several deviations from an ideal perfusion measurement were apparent.
Some could be traced to the shortfalls inherent in the invasive thermal model for surface
measurements using these simplified conditions. The major measurement issues were identified
as follows:
5.4.1 Motion Artifacts
In operation, the imposition of the temperature step, AT, results in the development of a thermal
field in the skin tissue around the heated probe tip. If the sensor moves relative to the tissue, the
field is no longer fully developed for the new sensor location. This results in a power spike
proportional to the distance moved, which creates an artifactual increase in perfusion and non-
physiological spikes in the perfusion data (see Figure 5.8).
The invasive probe uses a data processing algorithm to detect motion artifacts and take
appropriate action depending on the magnitude of the artifact. If the rate of change of perfusion
or power is greater than a specified, physiological threshold, an automatic recalibration to
determine the thermal conditions in the new location is conducted in situ. For invasive
measurements in relatively homogeneous tissue, the perfusion is relatively constant throughout
the tissue and the recalibrated perfusion values typically match pre-artifact values. The contact
geometry between the probe and the tissue usually remains constant as well for the spherical
thermistor embedded in the tissue. However, skin tissue perfusion is often much more
heterogeneous across a small surface area. Small perturbations will often lead to a much different
post-calibration perfusion measurement, either from relocation of the measurement site or
distorted contact geometry.
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Figure 5.8 Motion artifact during perfusion measurement
5.4.2 Sensor-Surface Tissue Contact
The concept of the TDP technique for measuring thermal conductivity is based on the
assumption that a known heat generated within a calibrated probe is transferred to a tissue
medium where it is dissipated by conduction and convection effects. the thermal contact between
the thermistor and the tissue is assumed to be theoretically perfect (i.e. no thermal contact
resistance), which is nearly impossible for skin surface measurements. A spherical thermistor on
the skin surface can only interrogate tissue along a hemispherical profile. On fingers, this contact
surface is covered with uneven ridges, known as dermal papillae, which comprise a person's
fingerprint. Microscopic pockets of air can form in the spaces between the ridges and
compromise the effectiveness and reproducibility of heat transfer.
An attempt was made to decrease the effect of skin surface irregularities by wetting the surface
of the skin with ultrasound transmission gel, which is routinely used to couple an ultrasound
transducer with the skin and provide an acoustic pathway. Just as it is used in ultrasound to
eliminate air from the interface and adapt to the contours of the skin, transmission gel was used
to increase thermal communication between the sensor and the skin. However, the consistency of
contact geometry is still a large source of variability. As will be discussed in Chapter 6, the use
of a sensor housing that maintains constant contact pressure and interface geometry could
increase the consistency of surface heat transfer.
5.4.3 Undetectable Baseline Perfusion
In some instances, the sensor would measure a perfusion value of zero. Small perturbations of
the sensor (pressing on the foam insulator, moving the finger) would cause temporary increases
in perfusion, indicating that the sensor was inappropriately applied to the skin or the thermal
communication was not optimal (see Figure 5.9). In some of these cases, basal perfusion may
have also been low in the subject's skin, such as in people with colder hands.
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Figure 5.9 Baseline measurement is undetectable. Pressing on the probe causes perfusion spikes.
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5.4.4 Non-zero Perfusion During Occlusion
During tests of reactive hyperemia, it is expected that perfusion will decrease to zero during
occlusion (see Figure 5.10A). In many cases, this did not occur; instead, perfusion would
decrease to a fairly constant non-zero value after blood flow was occluded (see Figure 5.10B).
Also, perfusion would sometimes drop to what would seem to be a negative value based on the
shape of the temperature cool-down curve at the level of zero perfusion (see Figure 5.10C). The
perfusion monitor does not measure perfusion below zero. In any case, the subsequent reactive
hyperemia still exceeded baseline perfusion values and it is clear from the sample data that
perfusion fluctuations over time are well-tracked by the sensor. Furthermore, the magnitude of
measured perfusion is quite close to expected perfusion values, which are statistically on the
order of 20 ml/I 10gmin in a thermoneutral environment. The deviations from expected values
can occur from non-ideal contact between the sensor and the skin, such that the actual
measurement deviates from the assumed thermal model conditions. The thermal environment of
the skin can also change over the course of a measurement (spatially or otherwise), shifting the
perfusion values up or down.
Seconds
Figure 5.10 Perfusion during occlusion does not reflect absolute zero flow (no flow). Occlusion during PORH
should establish a no-flow state. Instead, (A) shows a perfusion measurement with a occluded flow value close to
zero. (B) depicts a positive shift in expected value of perfusion during occlusion. A negative value of perfusion is
extrapolated from the perfusion measurement in (C).
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5.5 Physiological Issues
5.5.1 Baseline Temperature Fluctuations
A major source of measurement uncertainty occurs from wide variations in baseline skin
temperature. Unlike environments in which the sensor is completely enclosed in tissue with
significant thermal stability, skin temperature undergoes dynamic fluctuations in time due to its
role in thermoregulation and is often influenced by a combination of internal and external
factors. In addition to heat conduction from underlying subcutaneous structures, blood
convection warms the skin by transfer of heat from the core. This heat transfer process is due to
perfusion and plays the most influential part in determining overall skin temperature. However,
the skin will also constantly lose heat to the environment by radiation, convection, conduction,
and evaporative cooling. These changes are most pronounced in the extremities where AVA are
present. Therefore, it is critical that the conditions under which skin temperature is measured and
used to approximate blood flow are as closely controlled and defined as possible. External
influences (e.g. changes in room temperature, contact with other surfaces, air currents) should be
kept to a minimum to ensure skin temperature changes reflect physiological phenomena.
Baseline temperature fluctuations occur even in thermally stable environments due to intrinsic
oscillations in skin perfusion (see discussion in Section 2.3). Moreover, the heterogeneous nature
of skin surface tissue is manifest in both its vascular structure as well as its seemingly random
spatial pattern of perfusion. Thus, temperature varies not only with respect to time, but also with
respect to location. This poses a considerable challenge for the accurate calculation of perfusion
since an experimental value of intrinsic thermal conductivity is determined from the initial
propagation of the thermal field based on applied power, P, and the temperature step, AT. This
temperature step is the difference between the initial baseline tissue temperature, Ti and the
volume average temperature of the heat thermistor. Once the AT is established, tissue
temperature is monitored by the sense bead and the subsequent perfusion signal is calculated
based on this value. If the temperature gradient between the heat and the sense thermistors
changes such that the baseline temperature (at the sense location) is no longer a true surrogate
representation of the basal temperature at the location of the heat thermistor, this change in
gradient will lead to a .... in the calculated perfusion value.
Figure 5.11 shows a segment of perfusion and temperature data in which large fluctuations in
perfusion are evident in the perfusion signal. When compared with the temperature measurement
over the same time window, it is clear that the two are correlated. Temperature is clearly a
function of the skin perfusion over time and these changes can be closely monitored by the
preliminary noninvasive sensor.
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Figure 5.11 Temperature fluctuations in resting skin perfusion and temperature. Large variations in measured
perfusion are reflected in temperature changes corresponding in time.
5.5.2 Variability of km
Perfusion is calculated at a given tissue point based on an experimentally determined value of
km (the intrinsic thermal conductivity) at that same point in the tissue. The value of km is
calculated at the start of every perfusion measurement period and assumed to be constant
throughout the period (5-120 minutes). However, multiple repeated measurements taken at least
15 minutes apart show that the calculated skin conductivity changes over time. Many factors
have an effect on the value of km. Due to the nature of the conductivity algorithm, baseline
temperature fluctuations in the skin can affect the calculated value of km. Futhermore, perfusion
fluctuations and non-ideal contact between the sensor and the tissue can lead to artifact in the
perfusion extraction.
One explanation for variability in the value of km is that the natural state of skin hydration
changes from measurement to measurement. The water content of skin tissue plays a major role
in determining its intrinsic thermal conductivity. Moreover, water content is not evenly
distributed between the various layers of skin. While the dermis contains about 80% water, the
stratum corneum (the most superficial layer of the epidermis) is made up of about 30% water
[250]. The degree of surface skin hydration depends primarily on the penetration of water from
the dermis, water loss to the environment (e.g. evaporation), and water acquired from ambient
humidity [251]. Variation of these factors over the course of a measurement can change skin
water content and conductivity, giving rise to inaccurate perfusion values (physiologically
induced artifact).
An important function of the capillary bed is fluid exchange with the surrounding tissues. The
magnitude and direction of water movement across the capillary walls arise from a balance
between the hydrostatic and osmotic pressures across the membrane. Increasing the intracapillary
hydrostatic pressure favors movement of fluid from inside the vessel to the surrounding
interstitial space, while increasing the concentration of osmotically active particles within the
vessel favors the reverse. However, hydrostatic pressure is the principle driving force for
capillary filtration (outward movement of water) and exists as a gradient within the capillaries
(highest at the arteriolar end). Moreover, changes in venous resistance have a greater effect on
capillary hydrostatic pressure than similar changes in arterial resistance. In fact, about 80% of an
increase in venous pressure is transmitted back to the capillaries [15]. This is most apparent in
cases of edema in which increased venous pressure causes accumulation of excess fluid in the
tissues (e.g., congestive heart failure, widespread venous thrombosis, prolonged standing). This
becomes an important consideration in a test of reactive hyperemia where an occlusion of the
arm vessels causes pressure to increase in the venous network. As a result, capillary filtration
increases and there is a net movement of fluid into the tissue. This fluid increase during
occlusion can significantly change the intrinsic thermal conductivity of the tissue.
I investigated this effect in the reactive hyperemia data taken from individuals before and after
an occlusion. Figure 5.12 presents the pre-occlusion and post-occlusion value of the tissue
intrinsic conductivity calculated by the adapted surface thermistor sensor. In all cases, the post-
occlusion kmwas higher than the pre-occlusion km. Furthermore, the data from Subject 8 was
taken before and after a 7 minute occlusion, while the others were all occluded for 4 minutes.
Correspondingly, km increases by 27% whereas the other subjects with shorter occlusion times
show km gains between 2 and 7%. This is an interesting observation and should be a
consideration for future investigations.
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Figure 5.12 Measured intrinsic thermal conductivity of skin (ki) before and after occlusion in test of PORH.
In 8 subjects, km was calculated before occlusion and at least 10 minutes after the occlusion was removed. Subjects
1-7 exhibited an increase in measured conductivity between 2% and 7% after 4 minutes of occlusion. Subject 8
exhibited an increase in km of 27% following a 7 minute occlusion.
Also note that the value of km can be quite variable between individuals, reflecting differences in
skin hydration, composition and temperature. Nevertheless, the values obtained from the surface
sensor are within the range of previously determined conductivities of skin tissue that past
investigators have measured using a variety of methods [185, 227, 252, 253].
5.5.3 Multi-Phasic Perfusion Hyperemia
An observation has been made in multiple measurements of reactive hyperemia. Following the
release of the blood pressure cuff after an occlusion, there is often an initial hyperemia response,
followed by a return to near baseline values. Soon thereafter (on the order of several seconds to a
minute), the perfusion increases to a new peak value. Similar changes are seen in the temperature
measurement. The physiological explanation for this observation is not clear, although it may
entail vasoactive contributions from multiple local regulatory mechanisms, which operate on
different time scales. For example, the initial peak may be mediated by ischemia-induced release
of vasodilatory compounds in the microvasculature, while subsequent peaks may result from
endogenous, shear-stress-mediated release of nitric oxide. Moreover, there may be competing
effects from sympathetic nervous output or thermal regulatory mechanisms which sense rapid
changes in temperature. Future studies should investigate the mechanisms that lead to multi-
phasic reactive hyperemia responses as there may be important, additional information therein.
For example, it is possible that the relative contributions of distinct vasodilatory responses or the
time course of their action may differ between healthy individuals and those with endothelial
dysfunction. An example of a biphasic reactive hyperemia is shown in Figure 5.1.3.
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Figure 5.13 Biphasic reactive hyperemia following occlusion
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5.6 Methods of Data Analysis
The preliminary experiments involved measuring perfusion and temperature using the modified
invasive TDP (see Section 5.2.4). The quality of the data gathered for this thesis from
preliminary PORH testing often made it unsuitable for subsequent data analysis. Furthermore,
the data that was deemed sufficient for analysis was not obtained in a sample size large enough
to permit population comparisons between subject groups with regard to specific characteristics,
such as age or CVD risk factors. However, detailing the specific parameters that could be taken
from the perfusion and temperature data during a test of PORH establishes a significant
foundation upon which to base future testing among larger groups of subjects. In this section, I
will present representative data taken from sensors applied noninvasively to the skin of various
subjects' fingers with relevant analysis of defined parameters relating to changes in perfusion
and temperature following an occlusive blood flow challenge to the arm.
First, we must consider the limitations of a preliminary data analysis:
* The measured perfusion response to an occlusive challenge cannot be correlated with
degree of endothelial dysfunction.
* Only representative data is available and any conclusions drawn are speculative.
* The magnitude of the perfusion signal is not a reliable measure of absolute perfusion
values due to the model assumption of a 47n geometry.
5.6.1 Filtering
Data obtained from perfusion measurements includes a continuous record regarding the sensor's
operational parameters as well as the perfusion and temperature values. As is common for blood
flow data, there was a need to isolate the true data from measurement noise, artifacts, and
variability encountered during the acquisition procedure. Thus, the data was manually segmented
to account for the following information:
a. A written record of events during the measurement that affected perfusion data collection
(e.g. motion artifacts, test subject actions, sensor adjustments and/or replacement, etc.)
b. A written record of occlusion start and stop times
c. Knowledge of acceptable physiological limits on baseline and reactivity measurements
d. Automatically generated data regarding sensor operation throughout measurement period
(temperature fluctuations, power, km, thermistor bead cross-talk, etc.)
Perfusion and temperature were individually analyzed by separating measurement periods
corresponding to baseline, occlusion, and post-occlusion reactive hyperemia.
5.6.2 Perfusion Analysis
Post-occlusive reactive hyperemia in skin tissue is an increasingly common model of
microvascular reactivity function. The ability to obtain real-time continuous measurements
related to changes in microvascular blood perfusion has previously been explored by laser
Doppler flowmetry (Section 3.4.1). Many of those studied parameters can be adapted for
perfusion values obtained via the current thermal sensor.
Perfusion data that exhibited non-zero values during occlusion were normalized to reflect zero
perfusion at the lowest value reached during the occlusion period. A similar normalization is
carried out in laser Doppler flux data, such that biological zero (a non-zero value arising from
Brownian motion of macromolecules in the interstitial space) is subtracted from flux values in
the raw data [27].
Baseline perfusion was determined by calculating the average value of perfusion for the 1 minute
period prior to pressure cuff inflation (occlusion). The occlusion period was 4 minutes long
starting from the time of pressure cuff inflation (suprasystolic pressure) to the time of pressure
cuff release (subdiastolic pressure). The post-occlusion period was monitored for approximately
10 minutes, depending on the time it took perfusion to return to a baseline value. In cases where
perfusion did not return to baseline (no overshoot), post-occlusion data was acquired for 10-20
minutes and a peak was from the highest perfusion value reached within 5 minutes of releasing
the blood pressure cuff. Often, it was discovered the post-occlusion perfusion did not match
physiological expectations and a recalibration was performed to determine if the sensor
measurement had been compromised.
Individual sets of PORH perfusion data were analyzed by examining typical parameters that can
be derived from tests of reactive hyperemia (see Figure 5.14). Previous studies using laser
Doppler flowmetry have defined both magnitude-based parameters, such as peak amplitude or
percentage hyperemic response, as well as temporal-based parameters, such as time-to-peak
perfusion [254].
Magnitude-based parameters:
a) wpeak: Amplitude of post-occlusion peak perfusion
b) wmax: Maximum increase of perfusion during reactive hyperemia compared to baseline;
defined peak - Mean Baseline Perfusion
Opeak-Mean Baseline Perfusionc) w%: Percentage ofhyperemic response, defined as xMean Baseline Perfusion 100
Mean Baseline Perfusion
d) wAUC: Area under the perfusion curve following release
The area under the curve was not calculated in the data presented, as clear definitions have not
been established regarding the physiological basis for its use or interpretation.
Temporal-based parameters:
e) TTP,: Time-to-peak perfusion; time after occlusion cuff release until the post-occlusion
peak perfusion (wpak) is reached
f) Vmean: Mean velocity of the post-occlusion hyperemia increase, expressed as wpe•/TTPc
oI-
Figure 5.14 Representative PORH perfusion measurement with suggested parameters of reactivity
The most common temporal parameter used in laser Doppler flux data has been the time-to-peak
perfusion. Compared to brachial FMD, investigators have determined that a time-to-peak value
of greater than 10 seconds is a more specific index for the diagnosis of coronary artery disease
[122]. Still, as there is no currently agreed-upon set of parameters which consistently provide
reliable information on perfusion changes during PORH, studies have investigated the
reproducibility of common laser Doppler flowmetry parameters. In one such study, the
parameters corresponding to wmax, TTP., pak, and Vmean were found to be highly reproducible
parameters of laser Doppler PORH data (intraday and interday) [122].
5.6.3 Temperature Analysis
The skin is the primary mediator of temperature regulation and is subject to a wide range of
thermal influences. However, the role of perfusion is central to the maintenance of temperature
in the skin. Some methods have been proposed which place temperature changes during PORH
at the center of the investigation into endothelial dysfunction [222]. Therefore, parameters taken
from the temperature response following occlusion are important to an overall picture of vascular
reactivity in the skin (see Figure 5.15).
Magnitude- and Temporal-based parameters:
a) TNp: Nadir-to-peak temperature change (Tpeak - Tnadir)
b) TR: Temperature recovery, defined as Tpeak - Tinitial (initial pre-occlusion temperature)
c) T%: Percent of temperature rebound (compared to the change in temperature during
occlusion), defined as TR X 100
Tinitial-Tnadir
d) TAUC: Area under the temperature curve
e) TTPT: Time-to-peak temperature
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Figure 5.15 Representative PORH temperature measurement with suggested parameters of reactivity
One limitation of the present study could be relatively long cuff inflation and deflation durations
that took about 4 to 5 seconds. This relatively long deflation time may cause a minor delay in
time-to-peak (TTP, and TTPr). It may also introduce uncertainty into the times of occlusion and
initiation of the hyperemic response. Using a rapid cuff inflator that is able to inflate and deflate
within 1 second would probably lead to more precise TTP reading and improved reproducibility.
Also, note that in the following analysis, the peak temperature is defined as the maximum
temperature that corresponds to the peak hyperemia (normally the first temperature inflection
point post-occlusion). This became an important consideration when multiple temperature peaks
were apparent.
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5.6.4 Frequency Analysis
Clearly, the thermal sensor is capable of discriminating perfusion changes at both high and low
biological frequencies. It is also reasonable to assume that the magnitude of changes in perfusion
values corresponds with similar fluctuations in skin perfusion over time. These changes can be
analyzed in the frequency domain to gather data regarding intrinsic vasomotor regulation of
perfusion. With a sampling rate of 1 Hz, it is possible to discriminate frequencies up to 0.5 Hz. In
spectral analysis of laser Doppler flowmotion data, which is obtained at sampling frequencies
between 30 and 40 Hz, clear oscillations have been identified in the frequency ranges [255]:
* 0.009 - 0.02 Hz: Endothelial modulation of vascular tone
* 0.02-0.06 Hz: Neurogenic activity of the vessel wall (Sympathetic)
* 0.06-0.2 Hz: Intrinsic myogenic activity of vascular smooth muscle
* 0.2-0.6 Hz: Respiratory activity
* 0.6-1.6 Hz: Heart activity (cardiac cycle)
Therefore, the thermal sensor is well-positioned to measure the lower frequency vasomotor
components involved in skin perfusion flowmotion (heart rate can easily be measured
independently). The limitation thus becomes obtaining an adequate time interval of data with the
necessary frequency resolution to discriminate low frequency components. For example, a 5
minute set of data has a frequency resolution of 1/300s, or 0.0033 Hz.
Investigation into the mechanisms of skin blood flowmotion has created the potential for
determining regulatory patterns during basal conditions and in response to different stimulus,
such as ischemia. Rossi et al. have compared the spectral analysis of LDF perfusion flux data
from a baseline measurement against the flux following an occlusion [255]. In healthy subjects,
the investigators found a post-ischemic increase in the myogenic vasomotion component that
independently contributes to the prolonged phase of reactive hyperemia. They have also shown
an absence of post-ischemic increase of skin flowmotion related to the endothelial and myogenic
activity in chronic smokers, suggesting endothelial and smooth muscle cell dysfunction [182]. It
is suggested that vasomotion in the microcirculation contributes to an optimal blood flow
distribution in the vascular bed of tissues. Thus, the study of flowmotion has great potential for
illuminating specific features of the skin microcirculation in healthy and diseased states.
An example of a simple spectral analysis is provided in Figure 5.16. The analysis was performed
on a segment of the resting perfusion signal obtained from the palmar fingertip of a 23 year old
female subject (see Figure 5.16A). It is clear that frequencies lower than 0.1 Hz play a large part
in the measured perfusion oscillations (by several orders of magnitude) (see Figure 5.16B). The
frequencies that are most identified in the perfusion signal seem to result from endothelial
activity and sympathetic activity, which are local perfusion control mechanisms (see Figure 5.16
C). However, there is undoubtedly the need for selective filtering as it is clear that a simple
spectral analysis does not fully describe the oscillatory patterns of skin blood flow. Indeed, the
magnitude of oscillation at a specific frequency does not imply a higher proportion of control.
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Figure 5.16 Spectral analysis of perfusion signal measured by thermal sensor. (A) Basal perfusion signal
measured from fingertip of 23 year old female subject. The indicated time window is analyzed in the
frequency domain in (B), power spectral density (note log scale) and (C), simple spectral analysis zoomed in
on low frequency components.
60
E
4
O
m
4t
we
1600
5
' i I I I
* PAA
I
............................................ ..
.. . .... ....... ..··-- · · ·
5.7.1 24 year old Male, Healthy
The perfusion and temperature data during a test of PORH is presented for a healthy, 24 year old
male with no family history of heart disease, diabetes, or atherosclerosis in Figure 5.17. Baseline
perfusion was calculated as the average perfusion 1 minute prior to inflation of the arm blood
pressure cuff. Following the occlusion period, there is a rapid increase in perfusion and
temperature, followed by a substantial drop in both values. Another rise in perfusion and
temperature is seen shortly thereafter. This is an example of the multi-phasic phenomenon
mentioned in Section 5.5.3. The relevant parameters are displayed on the perfusion and
temperature plots as examples of possible data analysis (ref. Sections 5.6.2 and 5.6.3).
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Figure 5.17 Perfusion and Temperature during test of PORH in 24 year old, healthy male. The relevant
parameters are calculated as described in Section 5.6.2 and 5.6.3)
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5.7.2 30 year old Male, Cigarette Smoker
Another example of data taken during a test of PORH is shown in Figure 5.18. The subject was
an active 30 year old male who reported smoking cigarettes. Similar parameters of reactivity to
the previous analysis of Figure 5.17 are displayed. It is clear that the peak reactive hyperemia has
a much lower magnitude compared to the previous subject, although both had similar baseline
perfusion. Moreover, the post-occlusion perfusion returns to pre-occlusion levels immediately
following reactive hyperemia, with no indication of the sustained, elevated perfusion that would
be expected following a substantial period of ischemia. The temperature response also contrasts
with the previous subject. Rather than exhibiting a temperature rebound exceeding the initial pre-
occlusion temperature, the temperature increases to a peak value 0.304"C less than the initial
temperature. A new baseline temperature seems to be established as a result, since the
subsequent temperature data remains relatively constant around this new value.
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Figure 5.18 Perfusion and Temperature during test of PORH in 30 year old, male, smoker. The relevant
parameters are calculated as described in Section 5.6.2 and 5.6.3)
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Design of the Noninvasive Sensor
6.1 Design Issues to Address
The design of the non-invasive sensor must satisfy the following specifications:
* The sensor must be in good thermal communication with the tissue surface.
* The sensor should be applied to the tissue without causing capillary collapse or distorted
regional blood flow.
* The sensor should be insulated from environmental changes on all sides except the
sensor-tissue interface to maximize the signal and simplify the analysis.
* The sensor must be applied in a suitable configuration that promotes the analytical
extraction and interpretation of perfusion values from the resulting thermal field.
* The sensor should be low cost and easy to apply in a reproducible fashion.
The preliminary data shows that noninvasive perfusion measurements can be obtained using the
invasive thermal model. This is reasonable based on previous work with the invasive sensor and
its data extraction algorithm in which the fundamental heat transfer processes are modeled at the
capillary level for a variety of soft tissues, including brain, liver, kidney, muscle and skin.
A significant effort has been made towards optimization of a sensor contact pressure by
designing appropriate sensor housing that controls the sensor protrusion depth into the tissue. To
permit accurate measurement of perfusion in the skin, the contact pressure between the sensor
and skin tissue, as well as the sensor protrusion depth, must not exceed values that may alter
local perfusion. At the same time, the contact pressure should be high enough to ensure
consistent thermal communication between the sensor and skin, as it is essential for extracting
accurate perfusion values. Multiple housing designs have been investigated for reproducibly
mounting and applying the noninvasive thermistor sensors to skin. Design criteria include:
* Contact pressure such that sensor displacement into the compressed tissue is both highly
reproducible and less than 1 mm (-0.6 mm) to avoid significant capillary collapse
* Minimal thermal conduction paths from the perfusion sensor to any sensor encasement to
the environment thus rendering perfusion extraction less complex
* Thermal isolation of the sensor from environmental temperature variations
* Sensor adhesion to skin in manner that does not alter regional blood flow
* Compatibility with wetting agents that consistently enhance sensor-skin thermal
communication
* Noninvasive sensor configuration that is simple in concept and can be readily fabricated
reproducibly at low component and labor cost
Chapter 6.
Configuration is in a shape that facilitates the calibration procedures necessary to
determine those sensor thermal characteristics, which in turn are necessary to permit
accurate measurement of temperature, tissue thermal properties and the accurate
extraction of perfusion
6.2 Geometry
The sensor shape governs its interface with the tissue as well as the thermal field generated
during a measurement of perfusion. Therefore, an appropriate geometry will minimize contact-
induced perfusion artifacts and simplify the thermal model from which tissue thermal properties
and perfusion are determined.
6.2.1 Disk
Two disk-shaped surface thermistors were proposed by Steven Charles in 2004 [247]. One
consists of a flat, circular disk thermistor that rests flush against the tissue surface and is
insulated on all other exposed surfaces. The other consists of an inner heated disk and an outer
ring. The two are thermally isolated from each other by a thin insulating ring and the temperature
is controlled in the disk while the power required to maintain this temperature is used to calculate
perfusion. Both were modeled as one-dimensional infinite slabs (see Figure 6.1). The disk was
also modeled as a one-dimensional hemispherical shape as the isotherms in tissue heated by a
disk approach those of a hemispherical solution at large distances. A finite difference analysis
allowed him to determine that a disk design with a hemispherical model was sufficient for
measurement of perfusion within clinically acceptable error limits. However, disk models
suffered from edge effects and errors were quite large. Charles concluded that generally, errors
caused by approximating two-dimensional geometries by a one-dimensional model were too
large for clinical acceptance.
6.2.2 Hemisphere
As in the invasive TDP, a nearly spherical thermistor surrounded by tissue allows for
simplification of the governing heat equations to a one-dimensional model in spherical
coordinates. Both transient and steady-state solutions exist for a spherical thermistor embedded
in perfused, infinite tissue. Due to spherical symmetry, the spherical solution is valid for a
hemispherical probe embedded in a semi-infinite solid, where the free surfaces of the probe and
tissue are insulated.
Figure 6.1 Two-dimensional noninvasive designs with corresponding one-dimensional models considered by
Charles, 2004. [247]
6.3 Tissue-Sensor Interface
A suitable wetting agent that increases the thermal communication between the sensor and the
skin may aid in obtaining reliable, repeated perfusion measurements. Ultrasound gel has been
used with some success and no negative effects. However, it is possible to use liquids and gels of
different types to determine which are most appropriate. One potential substance is thermally
conductive grease, which has the ability to provide a highly conductive interface with minimal
contact resistance.
6.4 Sensor Fixation and Placement
The thermistors must mate with the housing in a reproducible manner to achieve consistent
measurements. The currently available thermistors have specific dimensions, which dictate the
internal dimensions of the sensor housing. For the sensor I am proposing, the heat thermistor has
a bead diameter of 0.028 inches (0.71 mm) and the sense thermistor has a diameter of 0.017
inches (0.43 mm). The thermistor leads are contained in a flexible catheter tubing with the
thermistor beads extending from the end. The beads must be fit into a housing which thermally
insulates the thermistor beads on all surfaces except for the tissue interface. Furthermore, the
sensor must be applied with the appropriate contact pressure, which preliminary testing as shown
to be 0.5 mmHg.
6.5 Initial Designs and Rapid Prototyping
Many different sensor and thermophobic sensor housing configurations have been considered.
The sensor housing addresses many of the issues related to skin surface perfusion measurements:
* By fixing the thermistors at a defined location relative to the skin tissue, the depth of
displacement can be precisely controlled to avoid altering local perfusion through
capillary collapse.
* The insulating material and thermistor configuration serves to thermally isolate the sensor
so that the dissipated heat is directed into the tissue and is consistent with the thermal
model governing perfusion extraction.
* Mounting the sensor within the housing provides additional structural strength and is able
to mate the sensor, the fragile internal lead wires and the insulating material.
* Fabrication of the housing can be accomplished inexpensively and with controlled
reproducibility.
6.5.1 Molded Design
One design was proposed by Chris Savage, an undergraduate in Mechanical Engineering [256].
The "bead holder" consisted of an interface that held the thermistors in a reproducible orientation
with respect to the tissue upon which it would be placed. Small, sharp projections reduce the area
of contact with the thermistor and are able to thermally isolate the sensor. A CAD model
(SolidWorks) is shown in Figure 6.2 detailing the internal geometries. The design was initially
realized through rapid prototyping, followed by testing the effectiveness of the interface. Rapid
prototyping of the various designs was carried out on a ZCorporation Spectrum 510 high-
definition, full-color 3-D composite prototyping printer at the MIT Media Lab. The 3-D printer
receives a solid model file as an input and builds prototypes layer-by-layer with a plastic and
resin composite. These prototypes give accurate geometries and the process allows production of
tens and hundreds of parts in a batch with different designs within the batch.
Figure 6.2 Solid model of proposed thermistor bead holder, designed by Savage, 2007 [256]. (A) Bottom face
of thermistor holder displaying internal geometries designed to thermally isolate thermistor during measurement. (B)
Opposite face of thermistor holder showing relative size of bottom flange for anchoring to skin tissue (by adhesive).
For still greater fidelity and to gain an understanding for the physical interface of the holder with
the sensor, the part was made on another rapid prototyping system, the inVision si2 3-D modeler
(3D Systems), which thermally deposits cross sections of acrylic plastic layer-by-layer. This 3-D
printer is capable of printing with a z-axis resolution of 800 dots per inch (dpi) and 656 dpi in the
x- and y-axes. A part is supported by wax that encases the acrylic so that the final part is revealed
after melting away the wax. After experimenting with the interface between the sensor and
cradle, certain adjustments were made to the dimensions to ensure proper fit and placement of
the sensor bead. Subsequent iterations called for the fabrication of different cradles exhibiting a
variety of depths of bead protrusion between 0.01" and 0.015." Figure 6.3 shows magnified
photographs of an acrylic prototype thermistor holder made in this way.
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Figure 6.3 Three-dimensional printed acrylic prototype thermistor bead holder. (A) Bottom (skin-side) view of
holder revealing internal geometries. (B) Bottom view of holder with sensor in position. (C) Side view of holder shown
with protruding sensor thermistor bead.
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The final realization of this design would be most appropriately produced by injection molding,
which is cost effective for manufacturing small parts in large quantities. However, the process is
limited by the internal contours of the injection mold and is not customizable for the most
appropriate thermistor fit. Furthermore, the complex internal geometries of the holder would
introduce similar complexities in the corresponding mold, which must be manufactured to
specification. This aspect is limited by the machine limits in milling the mold. Another concern
in manufacturing the part was supplying enough pressure during injection molding to introduce
molten thermoplastic material into the small crevices and projections of the small mold. These
limitations made it unrealistic to pursue injection molding as a method of manufacturing this
part.
6.5.2 Extruded Design
An alternative method of forming the sensor housing was suggested by Robert Poirier of Dunn
Industries, Inc. (Manchester, NH). His experience with the medical device industry, particularly
in tubing design, aided in the conception of an extrusion from flexible tubing material with a
suitable cross-section to accommodate sensor thermistors in the required orientation.
Thermoplastic Extrusion
Plastic extrusion is a steady state and high-volume manufacturing process that forms raw
thermoplastic polymers into a long, continuous profile. The process involves feeding small beads
of the desired material, called resin, into an extruder barrel with a rotating screw, where molten
polymer is produced through a combination of appropriate melt heat, pressure, and friction (see
Figure 6.4). The molten polymer then flows through the barrel to a breaker plate, which removes
contaminants and creates back pressure in the barrel. The shape of the tubing is defined by a die
located at the end of an extruder barrel. The die creates tubing with a specific profile and can be
designed to take on a variety of contours. Hollow sections within the tubing are extruded by
placing a pin or mandrel inside of the die to create the lumens within the extruded shape. The
extrudate from the die is cooled and wound onto a spool. One limiting element of extrusion is the
linear nature of the process, which requires that the cross-section of the part remain constant
throughout the entire length. Injection molding, on the other hand, is a cyclic process which
produces discrete products with varying cross sections in each axis.
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Figure 6.4 Plastic extruder cut away to reveal operating components
It was concluded that the intricate internal geometries for precise placement of the thermistors
could be formed during the extrusion process and the tubing would provide both versatility and
flexibility for the sensor design. These extrusions could be manufactured from medical-grade
tubing material in large quantities at a low cost. This design allows the discrete housing
necessary for an individual sensor to simply be taken from a linear tubing of a fixed cross-
sectional profile.
Design and Prototyping
However, initial testing of the physical interface was necessary before an extrusion die with
fixed geometries was fabricated. Figure 6.5 shows one such design that holds the heat and sense
thermistor beads of the sensor in extruded channels, isolated by three sharp projections that
reduce the area of contact between the thermistor beads and the extruded channels. These
projections reduce the natural heat conduction paths into the housing. The sensor is also naturally
insulated from environmental temperature variations by an appropriate thermally insulating
tubing material and the air contained within that tubing. The sensor configuration would be
placed on top of the tissue surface, where the individual thermistors maintain a fixed depth that
would not allow for significant perfusion disturbances.
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Figure 6.5 Extruded tubing with channels designed for thermistor beads fixed at specified depths relative to
the skin surface. (A) Cross-section of extrusion shown with mock thermistor beads showing degree of contact
between sensor beads and extrusion. (B) and (C) show different angle views of a 0.5 inch extrusion of (A).
To gain an understanding of the interface between the extruded design and the sensor, multiple
iterations of extruded cross-sections were printed in acrylic on the rapid-prototyping machine in
four-inch long pieces. We varied the sensor protrusion depth, channel shape, tubing shape, and
the profile of the extrusion channels for thermistors of various size and number. The acrylic
prototypes lack the thermal material characteristics necessary for a final prototype. However, the
geometry of the interface between the extrusion channels and the sensor allowed for preliminary
data to be taken on the skin of the hand indicating that relative perfusion could be measured
using the suggested sensor configuration. Furthermore, vascular responsiveness and endogenous
vasomotor activity were readily obtained from the perfusion data.
Figure 6.6 shows a configured sensor that incorporates the extruded housing design. Computer-
drawn solid models of the sensor are displayed with magnified photos of an acrylic prototype
sensor. As shown, the housing holds the thermistors within the channels at a fixed depth and is
enclosed in a circular foam pad that has an adhesive coat for fixation to the skin surface. The
protrusion of the thermistors determines the depth that the noninvasive sensor will project into
the skin and is the most critical parameter to make reproducible. A rapid prototype of the
extrusion was made and placed in the anticipated configuration with one heat and two sense
beads (a slight modification from the original design).
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Figure 6.6 Multiple perspectives of solid model and prototype of alternative extruded housing design. (A) is a
photograph of an actual prototype senseor. (B)-(D) show th conceptual solid model displaying a central heating
thermistor and two passive sense thermistors connected in series to adjust for baseline temperature. Magnified
selections of (C) and (D) are provided by (c) and (d), which are high-magnification photos of the actual prototype.
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Our next generation noninvasive sensor will likely utilize commercially extruded sensor housing
produced by Dunn Industries (Manchester, NH), a leader in medical plastics. The tubing
material will be made of SantopreneTM, a thermoplastic elastomer (TPE) that consists of a
mixture of ethylene-propylene-diene monomer (EDPM) copolymer and polypropylene. It
combines the characteristics of vulcanized rubber (heat resistance, low compression set) and the
processing ease of thermoplastics.
6.6 Proposed Sensor Design
Considering all the relevant design criteria and collective experimental experiences to date, I
propose the sensor design shown in Figures 6.8-6.10 as a candidate design for an ideal thermal-
based noninvasive perfusion sensor.
This design incorporates the following features which permit a simple, reproducible, and reliable
method of measuring surface perfusion:
* Commercially available and inexpensive spherical thermistors are mounted in the
extrusion in a hemispherical geometry. This is an ideal geometry with respect to the
thermal models, thus allowing perfusion to be determined from an analytical solution.
* An extruded sensor housing thermally isolates (and insulates) the thermistors in order to
approximate ideal adiabatic conditions. The nature of the extrusion process produces the
housing in a linear fashion, enabling large quantity production at low cost.
* A flexible foam pad made of thermally insulating material and coated with a skin-
compatible adhesive. The foam pad insulates the sensor from unstable environmental
conditions and provides the adhesion necessary to maintain adequate contact pressure
relative to the skin.
To assemble the sensor, the self-heated thermistor (perfusion sensor) and the baseline tracking
sense thermistor are mounted in the extruded sensor housing shown in Figures 6.7-6.10. Proper
contact between the skin and sensor is ensured by the set protrusion depth of the sensor (see
Figure 6.9). This value is much smaller than the depth at which perfusion is altered by capillary
collapse and is still adequate for maintaining appropriate thermal communication between the
sensor and the tissue. Sensor thermal insulation is established by the three small contact points in
the housing, which minimize thermal conduction paths away from the sensor. The housing is in
turn contained within the body of a flexible, adhesive foam pad, which lends additional
insulation from the effects of environmental temperature variations. Electrical leads from the two
thermistors are thermally anchored to the housing to minimize heat leakage. Furthermore, the
catheter containing the leads is contained within the housing to minimize damage to the lead
wires which might result in current leakage. The complete assembly of the sensor is shown in
Figure 6.10C. To apply the sensor, the adhesive face containing the exposed sensor is simply
affixed to the skin surface.
The final extrusion profile iteration had to account for a number of design specifications:
* There are constraints on the inclusion of sharp projections in an extrusion. Within the
slots, there are sharp edges which hold the thermistor beads in place, while minimizing
contact surface area to reduce heat conduction paths. These sharp projections in the slots
were given a slight curvature to balance the manufacturing constraints and the thermal
model constraints.
* Further efforts to reduce heat conduction from the thermistor to the extrusion led to the
addition of lumens within the extrusion (0.01" in diameter), which minimize conduction
paths near the lateral sensor/extrusion interfaces.
6.6.1 Design and Manufacture of Sensor Housing
The final housing design is presented in Figure 6.7 with the relevant dimensions custom-fit to the
currently available thermistor sensors (units in inches as required by toolmaker). A model of the
anticipated extrusion is shown in Figure 6.8. The housing specifications were provided to Dunn
Industries for manufacture of the extrusion. However, the first step in the manufacturing process
involved contracting an outside source for the necessary tooling (extrusion die). The difficulties
in manufacturing such a small part with specific geometries led to a tremendous delay in the
actual manufacture of the part (e.g. crushed tooling, unacceptable products). Furthermore, the
extrusion process was hampered by machine malfunctions that damaged both the tooling and the
extruded product. Several repetitions of these problems prevented completion of the part in the
time necessary to test the sensor for inclusion in this thesis. However, the proposed sensor design
and assembly is presented for use in the future.
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Figure 6.7 Dimensioned cross-section of sensor housing for extrusion die manufacture
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Figure 6.8 Three-dimensional model of a small length of sensor housing extrusion
6.7 Calibration
The calibration of the invasive TDP is accomplished by inserting an assembled probe into
different media of known thermal conductivities, achieving a 427 geometry with respect to the
surrounding medium. In this case, all of the heat that leaves the thermistor enters the tissue
medium. A similar situation would be desirable for the noninvasive sensor, as this would allow
for the sensor to be calibrated in the same way as the invasive TDP.
As was discussed in Section 5.1.2, the TDP is calibrated by first establishing a resistance-
temperature relationship for each thermistor. Then, the conductivity of the bead and the effective
bead radius, which define the heat transfer properties of the thermistor, are determined. This
procedure allows for rapid calibration of probes in bulk. Assuming that the noninvasive sensor
housing provides sufficient insulation to direct the bulk of heat transfer into the tissue, the same
calibration procedure would be adequate. This assumption can be tested by performing the
standard calibration in a 4n geometry and comparing data taken from its use in a 2n geometry
(surface application).
6.8 Sensor Assembly
The final sensor will be assembled from its component parts:
* Thermistors :
o Heat thermistor bead: 0.028" diameter
o Sense thermistor: 0.017" diameter
o Positioned 8 to 10 mm apart, extending from medical grade catheter tubing (see
Figure 6.10A)
* Extruded Housing
o Flexible medical-grade Santoprene thermoplastic
o Extruded with given cross-sectional design
o Channels along length of extrusion designed to hold thermistors with
hemispherical bead protrusion
* Foam pad
o Skin-compatible, removable adhesive coating on side applied to the skin
o Thermally insulating foam material
Figure 6.9 presents the cross section of the thermistor housing with thermistors placed in the
extruded channels. Note that the beads are insulated from the environment by the housing design,
which minimizes the area of contact between the projections from the housing and incorporates
pockets of air within the space around the thermistors. The interface with the skin on the bottom
face of the housing allows a hemispherical portion of the thermistors to protrude a maximum
distance of 0.35 mm into the skin, which is a much smaller depth than that at which perfusion
would be affected (1.5 mm).
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Figure 6.9 Cross-section of thermistor beads placed in sensor housing
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The final assembly of the sensor is shown in Figure 6.10. First, the thermistors are incorporated
into the extruded housing such that the lead wires wrap around the end of the housing and into
the catheter tubing, which is contained in the upper portion of the housing (Figure 6.10B). The
extrusion is then laid into the adhesive face of a foam pad such that the bottom of the extrusion is
flush with the adhesive face of the foam (Figure 6.10OC).
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Figure 6.10 Complete assembly of proposed noninvasive surface perfusion sensor. (A) Bottom face of proposed
sensor indicating relative distance from heat thermistor to sense thermistor. (B) Housing with thermistors placed in
extruded channels and electrical leads fed into tubing within the housing. (C) Final assembly showing placement in
adhesive foam pad.
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An assembled sensor will be applied to the surface of skin tissue where contact pressure is
maintained by the adhesive on bottom face of the enclosing foam insulator. A suitable wetting
agent can be used to enhance thermal communication and reduce contact resistance.
Figure 6.11 provides a schematic cross-section of the final sensor assembly on the surface of a
tissue.
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Figure 6.11 Schematic cross-section of assembled noninvasive sensor resting on surface of tissue
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Chapter 7. Conclusion and Recommendations
The goal of this research was to investigate the use of a noninvasive thermal perfusion sensor in
tests of post-occlusive reactive hyperemia for the determination of endothelial dysfunction as
detected in the digital skin tissue. To do this, several steps were taken that reflect the breadth and
potential in this field of research.
I explored the physiological mechanisms of skin tissue perfusion and reactive hyperemia and
considered how endothelial dysfunction may deregulate such mechanisms. The current research
suggests that skin microcirculation is an appropriate vascular bed for independent assessment of
endothelial dysfunction, although the fundamental mechanisms of reactive hyperemia may not be
the same as for conduit artery reactivity. Furthermore, there are regulatory components in the
time course of skin perfusion which may be differentially affected by disease states. Therefore,
absolute and continuous measurement of skin perfusion can reveal both temporal as well as
functional indices of global cardiovascular health.
I established the current clinical need for noninvasive perfusion measurement technologies and
for reliable tests of endothelial dysfunction by reviewing currently available noninvasive
methods which hold the greatest promise. Each method has distinct advantages and
disadvantages, and it is possible that a combination of these technologies can offer a greater
depth of understanding. The gap in cardiovascular risk detection occurs in people who have no
clinical symptoms of disease. Therefore, it is vital to develop new technologies which are safe,
reliable, noninvasive, inexpensive, and standardized between operators. As I have shown,
thermal perfusion monitoring has the potential to meet all these needs and can also reflect the
dynamic biology of the endothelium throughout the progression of atherosclerotic disease by
offering absolute parameters of functional health. It is possible that, with further development
and clinical studies, these parameters could provide prognostic information for patients and
encourage individuals to improve their overall state of health, as endothelial dysfunction has
been shown to be reversible. In addition to noninvasive applications, such a device could provide
quantitative analysis of the microcirculation during surgery (transplant, cardiac, vascular,
neurological, plastic, etc.), wound healing, tumor therapy and intensive care medicine.
I have performed an extensive review of the scientific literature regarding the systemic impact of
endothelial dysfunction and its manifestations in the coronary, conduit, and microvascular
circulations. These interrelations are necessary to establish validity for a technique which
measures endothelial dysfunction in the peripheral circulation as a surrogate for the coronary
circulation, where most cardiac complications occur. I discovered a clear need for a simple,
noninvasive diagnostic tool for endothelial dysfunction in both experimental and clinical settings
to evaluate and monitor the microvascular consequence of conditions such as heart disease,
peripheral arterial disease, hypertension, shock, or diabetes.
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I have also summarized the technological innovations that have led to the development of the
minimally invasive Thermal Diffusion Probe (TDP), which measures absolute tissue perfusion in
small volumes of tissue. This technology forms the foundation for the thermal method that I
propose to use to measure skin blood flow. Its validation in minimally invasive applications has
positioned it for a natural step toward research in noninvasive applications.
The final part of my thesis consisted of investigating the feasibility of a noninvasive thermal
sensor by performing preliminary tests of PORH on the digital skin of volunteers using a
modified TDP. Although no conclusions could be drawn due to the small set of subject data, I
have taken significant steps to establish a protocol for reproducible measurement techniques.
Moreover, it is clear from the acquired data that surface perfusion can be accurately tracked in
real-time with a simple surface application of the exposed thermistor beads when care is taken to
insulate the surrounding environment. A presentation of representative data analysis further
establishes the potential parameters that can be used to gauge microvascular reactivity in the skin
using a thermal method.
Finally, I have presented the steps taken to design and manufacture a truly noninvasive perfusion
sensor based on the thermal requirements of a tissue surface perfusion measurement. Extensive
computer-assisted modeling was carried out to arrive at a suitable sensor design, while
communication with industrial manufacturers has further refined the feasible specifications of
such a design.
Further investigations should apply the design contained herein to establish the feasibility of
measuring surface perfusion using a sensor calibrated for invasive applications. While the design
of the sensor housing is a key step in facilitating this simplification of the thermal model, it is
necessary to test this hypothesis. Steps may also be taken toward establishing a dedicated method
of calibrating sensors noninvasively. The measurement issues discussed in Chapter 5 should
serve as guidelines for improving the measurement technique and enhancing reproducibility.
Once a sensor has been shown to measure perfusion in skin tissue in a reproducible and reliable
way (measuring temporal variations and absolute magnitude of perfusion), a more extensive
clinical study needs to be carried out to establish a link between thermal sensor-derived
parameters of reactive hyperemia and cardiovascular risk.
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